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ABSTRACT 
Merwilla natalensis (Planchon) Speta is ranked as one of the most commonly sold 
medicinal plants at most of the informal medicinal plant markets found throughout 
South Africa. The increasing demand for medicinal plants has resulted in over-
exploitation of many of the wild populations. Overharvesting has resulted in M. 
natalensis being declared vulnerable. Although this species is so popular, and reports 
state that the bulbs are used for a variety of ailments, very little is known about its 
pharmacological activity or phytochemical composition. 
Extracts were made from mature M. natalensis bulbs using hexane, 
dichloromethane, methanol and water. These extracts were screened for 
antibacterial, anticancer, anti-inflammatory, antischistosomal and anthelmintic 
activity. Antibacterial activity was evaluated using the minimal inhibitory concentration 
(MIC) assay. Methanol extracts displayed good antibacterial activity against both 
Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-negative 
(Escherichia coli and Klebsiella pneumoniae) bacteria. Anti-inflammatory activity was 
evaluated using the COX-1 and COX-2 bioassays. Dichloromethane extracts 
displayed the highest inhibitory activity against both COX-1 and -2 enzymes. (80% 
and 91 % inhibition respectively) Very good activity was displayed against the free-
living nematode Caenorhabditis elegans and the schistosomula worms of 
Schistosoma haematobium using microdilution techniques. Anticancer activity was 
evaluated using the biochemical induction assay (BIA) in which DNA-damaging 
properties are tested for. No activity was found using this assay, however, these 
results do not prove that M. natalensis does not have other anticancer properties. 
The phytochemical investigation of mature M. natalensis plants showed the 
bulbs to contain both saponins and bufadienolides. One of the bufadienolides had the 
same Rf value as proscillaridin A. Cytotoxicity tests reveal M. natalensis to be 
extremely cytotoxic, yet the bulbs are commonly sold at traditional medicine markets 
around South Africa. This cytotoxicity may be accredited to the presence of saponins 
within the bulbs. No alkaloids or tannins were detected in the bulbs. 
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ABSTRACT 
With the growing population in South Africa, there is an increasing demand for 
traditional medicines. This increasing demand is placing tremendous strain on natural 
populations growing in the wild . However, as the demand cannot continue to be met 
other sources are needed . Tissue cultured plants have been grown at two different 
regions of South Africa. These plants have been grown under different conditions to 
determine the optimal ones needed to grow M. natalensis as a commercial crop on 
small-scale farms. 
Plantlets taken directly from tissue culture were acclimatized successfully for 
cultivation by means of simple and cost effective methods. Cultivated plants were 
harvested on a six-monthly basis for a period of two years. Field cultivation produced 
bulbs of almost marketable size (±300g fresh weight) after 24 months. Bulb size was 
not dependent on additional fertilizer or irrigation. No significant differences (psO.05) 
were shown in the average dry weights of bulbs grown under different treatments 
(control, fertilizer without irrigation, fertilizer with irrigation). Leaf senescence and 
dormancy of young plants were prevented with irrigation. Flowering occurred after 24 
months, with the irrigation and fertilizer plot having the most flowering plants. TLC 
fingerprinting revealed differences in the chemical composition of the bulbs harvested 
at different stages of growth. Noticeable differences were found between bulbs 
cultivated at the different growing sites. 
Pharmacological screenings were done of the harvested bulbs to investigate 
the effect of age (time of harvest) and growing conditions on antibacterial, anti-
inflammatory and anthelmintic activity. Methanol extracts were screened against 
Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-negative 
(Escherichia coli and Klebsiella pneumoniae) bacteria. Variations in activity were 
found. The time of harvest had a significant effect (pSO.05) on biological activity, with 
the younger plants being more active. Antibacterial activity decreased with an 
increase in plants age. 
Methanol extracts were also screened for anthelmintic activity against 
Caenorhabditis elegans. Activity was found to increase with plant maturity. Irrigation 
was found to increase activity at the low rainfall (Fort Hare) site. Bulbs harvested 
from the irrigation treatment had significantly higher anthelmintic activity (psO.05) 
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than bulbs harvested from treatments without irrigation. Dichloromethane extracts 
from bulbs grown at both sites had high anti-inflammatory activity. There were no 
significant differences (psO.05) in the activity of bulbs harvested from the different 
treatment plots. The time of harvest had an effect on the inhibition of prostaglandin 
synthesis by COX-1 enzymes. 
This study provides not only scientific verification for the use of M. natalensis 
to some extent as a medicinal plant, but also important data needed to successfully 
cultivate this species as a crop for small-scale farming . 
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CHAPTER 1 INTRODUCTION 
1.1. Plants in Medicine 
Selection of plants from the wild to be used as medicines has occurred for 
centuries. The knowledge and administrative techniques of these traditional medicines 
have been passed from generation to generation (COUZINIER and MAMATAS 1986; 
LEWIS 1992). Plants were once the primary source of all the medicines in the world . 
More than 50 % of clinical drugs used today are made up of plant products or their 
derivatives (KINGHORN and BALANDRIN 1993). Although this number is high, about 
90% of the 119 plant derived pharmaceutical products currently marketed are derived 
from approximately 90 different plant species (FARNSWORTH 1994). Well-known 
examples of plant-derived medicines that are used as clinical drugs include quinine, 
morphine, codeine, aspirin, atropine, reserpine and cocaine (VAN WYK, VAN 
OUDTSHOORN and GERICKE 1997). If one considers that there are approximately 
500 000 species of higher plants, there remains an abundance of plants that have not 
been examined and these species may have the potential to be pharmacologically 
active and the source of new pharmaceutical drugs (FARNSWORTH 1994). It was not 
until the 1990's that the developed world started to pay attention towards indigenous 
traditional knowledge and cultures of under-developed Countries. Increasing interest in 
natural products led to increasing respect for the indigenous peoples and their 
knowledge (CORDELL 1995). 
Medicinal plant drugs can be divided into two broad categories. The first 
consists of complex mixtures containing a wide variety of compounds (concoctions) 
such as infusions, essential oils, tinctures or extracts. The second consists of pure, 
chemically active principles. These are stronger and more specific (HAMBURGER and 
HOSTETIMANN 1991). 
1.2. Traditional Medicine 
In most developing countries a large proportion of the population use traditional 
medicines either due to the high cost and unavailability of western medicines and 
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health care, or because the traditional medicines are more acceptable from a cultural 
and spiritual perspective (CUNNINGHAM 1988). Many traditional African medicines are 
regarded as food plants that are not poisonous and are eaten for therapeutic purposes 
in contrast to orthodox western medicines, which are in essence, poisons taken at low 
doses (IWU 1993). African traditional medicine is not as well documented as Indian and 
Chinese traditional medicine. Some of the African medicinal plants investigated for their 
chemical components contain compounds with interesting biological activity, which 
have proved to be therapeutically active (IWU 1993). 
The World Health Organisation's (WHO) resolution on a strategy to promote 
"Health for All" recognises that health is a fundamental right (PATEL 1983). The current 
modern health care cannot meet the needs of the entire world's population . LE GRAND 
and WONDERGEM (1989) proposed that there is a need to promote traditional 
medicine as a means to improve the health in many developing countries. 
Modern drugs available to remote villages often lack adequate information on 
their use, which can result in over-consumption and even drug abuse. Generally 
synthetic drugs have very high pharmodynamic effects, but this activity is in most cases 
accompanied by strong and even dangerous side effects. Medicinal plants do not have 
similarly high therapeutic potencies and show no serious side effects except for a few 
exceptions (NARANJO, 1995). 
1.3. Traditional Medicine in South Africa 
Medicinal plants form an important aspect of the daily lives and cultural heritage 
of many South Africans. Southern Africa has over 30 000 species of higher plants 
(VAN WYK, VAN OUDTSHOORN and GERICKE 1997). The Cape Floral Kingdom 
alone has nearly 9 000 species and is regarded as the most diverse temperate flora on 
earth (VAN WYK, VAN OUDTSHOORN and GERICKE 1997). With this kind of 
biodiversity it is not surprising that there are approximately 3 000 plant species that are 
used in traditional medicines. Three hundred and fifty of these are commonly used and 
traded medicinal plants (VAN WYK, VAN OUDTSHOORN and GERICKE 1997). Even 
today, a large part of day-to-day medicines are still derived from plants. South Africa 
has contributed to world medicine with the discovery of Cape aloes (Aloe ferox), buchu 
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(Agathosma betulina) and Devil's claw (Harpagophytum procumbens) . However, there 
is still a lack of detailed documentation on the use of medicinal plants in South Africa. 
This is an important issue since most of the traditional knowledge is passed down 
through the generations from one person to the next. With the increase in urbanisation 
and the loss of many traditional customs, traditional knowledge is gradually being lost 
(VAN WYK, VAN OUDTSHOORN and GERICKE 1997). 
Traditional medicine is still widely used by the majority of South Africans, 
especially as western medicines are not readily available to the majority of rural people. 
It is estimated that up to 80 % of the Zulu people use traditional medicines. For this 
reason, medicinal plants have become the focus of intense study in recent years in 
terms of conservation and as to whether their traditional uses are supported by 
pharmacological effects or merely based on folklore (CUNNINGHAM 1988; JAGER, 
HUTCHINGS and VAN STADEN 1996; MANDER 1997). Up to 60% of the South 
African population consult one of the estimated 200 000 traditional healers (VAN WYK, 
VAN OUDTSHOORN and GERICKE 1997). This is especially true in rural areas where 
traditional healers are more numerous and accessible than western doctors 
(CUNNINGHAM 1988). Traditional medicines are most frequently used by low-income 
groups, as it is considerably cheaper than Western medicines. This is prevalent in the 
KwaZulu-Natal region, which is known to have one of the highest incidences of poverty 
in South Africa (MANDER, MANDER and BREEN 1996). 
A wide gap exists between modern and traditional medical practices. Attempts 
are being made to try and narrow this gap through the establishment of Healer's 
associations. There is a need for more professionalism and regulation (SINDIGA, 
KANUNHA, NYAIGOTII-CHACHA and MWANGOLA 1995). In South Africa, the 
recognition of traditional medicine aims to improve the safety, availability and allow for 
wider application at low cost. With the increasing acceptance of traditional medicine as 
an alternative form of health care, there is an urgent need for an evaluation of 
traditional methods of treatment. A lot of importance has been placed on the screening 
of medicinal plants for active compounds. 
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1.4. Conservation of Medicinal Plants in South Africa 
The increase in demand for novel phytochemical drugs has coincided with the 
accelerated destruction of tropical rain forests resulting in an estimated loss of 20 000 
species over and above the normal rates of extinction (LEWIS 1992). 
South Africa has a rapidly increasing population that needs to be fed and 
housed. The increase in agriculture, forestry, industrial and urban housing 
encroachment has caused many wild medicinal plant resources to become threatened . 
Development of private and communal land has resulted in localised extinctions of 
many popular medicinal plants in KwaZulu-Natal (MANDER, MANDER and BREEN 
1996). 
Another threat to wild resources is the need for more medicinal plants. A large 
and active trade in medicinal plants exists in KwaZulu-Natal and other parts of South 
Africa. The increasing demand for medicinal plants has resulted in over-exploitation of 
many of the wild populations (MANDER, MANDER and BREEN 1996). There has also 
been an increase in non-specialist gatherers and commercial traders. These gatherers 
have little knowledge of traditional healing and sustainability (VAN STADEN 1999). 
This has been brought about due to the increase in unemployment and increasing 
demand for medicinal plants. In the past, professional herb gatherers and traditional 
healers used to collect and store plants according to their traditions. In this way they 
prevented overharvesting. Today, the urbanised healers purchase their ingredients 
from the street markets and stores which provides an income to many otherwise 
unemployed people. However, this has a negative effect on the environment, as this 
provides an incentive for the destructive harvesting of vulnerable medicinal plants (VAN 
WYK, VAN OUDTSHOORN and GERICKE 1997). 
The ever increasing demand for medicinal plants has resulted in a greater 
harvesting intensity being placed on the remaining natural resources (MANDER, 
MANDER and BREEN 1996). There is a growing need for sustainable use of natural 
resources and for enhanced supply by means of cultivation. VAN STADEN (1999) 
suggested that if the concept of sustainable use is to be effective, the population needs 
to be in equilibrium with the landmass it occupies. However, with South Africa's 
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growing population this equilibrium is seriously out of phase. Most of the natural 
populations have already been overexploited, and those that remain are largely within 
conservation areas. It is these conservation areas that are targeted for so-called 
sustainable harvesting. It is therefore believed that the demand for medicinal plants is 
already too large and that meeting the demand by sustainable use would be extremely 
difficult (VAN STADEN 1999). VAN STADEN (1999) suggested that the only real 
solution would be to develop the valuable medicinal plants as crops through small-
scale farming. The outcomes of this would be very positive, as not only would there be 
sustainable development and protection of biodiversity, but this would generate income 
for many through entrepreneurial farmers. 
Although the cultivation of medicinal plants has been suggested, there remains 
a lack of understanding with respect to the cultivation and economics of producing 
medicinal plants. This lack of understanding can be considered as one of the most 
limiting factors in the commercialisation of indigenous medicinal plants (MANDER, 
MANDER and BREEN 1996). There is an urgent need for field trail analysis on 
commonly used medicinal plants. Basic information on how to grow the plants, planting 
to harvest periods, yield, expected financial returns, storage and shelf-life is needed 
before small-scale farmers can be expected to venture into growing medicinal plants 
(JAGER and VAN STADEN 2000). JAGER and VAN STADEN (2000) suggested that 
if this information were available and the cultivation of medicinal plants was phased in 
properly, the financial rewards for small-scale farmers could be higher than the returns 
obtained from maize or sugarcane. 
1.5. The Genus Merwilla 
The genus Merwilla (SPETA 1998) is a relatively new genus that is comprised 
of species that were initially members of the genus Scilla. The genus Scilla has been 
under investigation many times and still remains a very controversial one. Initially, the 
genus Scilla was placed under the family Liliaceae, but now it has been placed into a 
new family known as the Hyacinthaceae that comprises of the four sub-families 
Hyacinthoideae, Ornithogaloideae, Urineoideae and Oziroeoideae (PFOSSER and 
SPETA 1999). 
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In 1970, JESSOP reviewed the genus Scilla sensu lato. The genus 
Ledebouria was initially placed under the title Scilla sensu lato, but JESSOP (1970) 
showed that cytological as well as anatomical evidence suggested otherwise. 
JESSOP (1970) recognised six Scilla species found in South Africa . These being 
Scilla dracomontana HILLARD & BURTT, S. firmifolia BAKER, S. kraussii BAKER, 
S. natalensis PLANCH., S. nervosa (BURCH.) JESSOP and S. plumbea LlNDL. In 
SPETA's (1998) review of the family Hyacinthaeae, the family was found to 
accommodate approximately 1000 species distributed into approximately 70 genera. 
This review showed there to be no true Scilla species existing in Africa south of the 
Sahara (SPETA 1998). Instead SPETA (1998) recognises there to be a new genus 
Merwilla, which consists of five species Merwilla dracomontana (HILLIARD & 
BURTT) SPETA (= Scilla dracomontana) , Merwilla kraussii (BAKER) SPETA (= 
Scilla kraussit) , Merwilla lazulina (WILD) SPETA (= Scilla lazulina) , Merwilla 
nata/ensis (PLANCHON) SPETA (= Scilla natalensis) and Merwilla plumbea (LiNDL.) 
SPETA (= Scilla plumbea). Four of these species are found in South Africa, Merwilla 
lazulina (WILD) SPETA is found in Zimbabwe. The other two Scilla species that were 
recognised by JESSOP (1970) to be found in South Africa, Scilla firmifolia BAKER 
and Scilla nervosa (BURCH.) JESSOP were recognised by SPETA (1998) to be 
Pseudoprospero firmifolium (Baker) Speta and Schizocarphus nervosus (BURCH .) 
MERWE respectively. 
1.6. Merwilla natalensis (PLANCHON) SPETA (= Scilla natalensis) 
Many of the species used in traditional medicines have bulbs as their main 
storage organ. South Africa has been regarded as having a treasure trove of bulbous 
plants. Many of these species have the potential to be exploited commercially both 
horticulturally and medicinally. One of the more commonly traded and used medicinal 
plants is Merwilla natalensis (= Scilla natalensis). 
1.6.1 . Distribution and Morphology 
Merwilla natalensis is a summer-growing plant, restricted to the eastern parts of 
South Africa (Figure 1.1 D), which experience summer rainfall, from the Eastern Cape 
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Province through Lesotho, KwaZulu-Natal, Free State and Swaziland to the Northern 
Province (JESSOP 1970). In KwaZulu-Natal it is found from the coastal plateaux to the 
Drakensberg escarpment where it is most common. The bulbs of this species are frost 
resistant and are usually associated with well-drained steep slopes and rocky sites, in 
Mistbelts and Montane Grasslands. However, this species has been found to be 
growing in soils with a high clay content in parts of the Drakensberg. 
Merwilla natalensis (Figure 1.1A) is a bulbous plant with broad, sharply tapering 
leaves arising from medium to large-sized bulbs of about 100 mm - 150 mm in 
diameter. The bulbs often grow in large groups and are mostly exposed above the soil 
surface. Brown, papery "scales", the remains of old leaves are found on the exterior of 
the bulb. The flowers are small, blue or purplish-blue in colour Figure 1.1 B) and are 
borne on long slender stalks of about 1 m in height. The blue flowers and broad leaves 
are what make S. natalensis distinguishable from the other South African Scilla species 
(VAN WYK, VAN OUDTSHOORN and GERICKE 1997). However, even with these 
rather distinctive characteristics, certain authors (JESSOP 1970) placed S. natalensis 
Planch together with S. dracomantana (now known as M. dracomantana) and S. 
kraussii (now known as M. kraussil) under the same species name Scilla natalensis. 
These three species have since been shown to be different species using 
morphological characteristics (HILLIARD and BURD 1982) and phytochemical 
evidence (CROUCH, BANGANI and MULHOLLAND 1999). VAN STADEN and PAN 
(2001) confirmed the differences between the species using random amplified 
polymorphic DNA (RAPD) makers. In the review by SPETA (1998) all three species 
were recognised as three separate Merwilla species. In this study the Merwilla 
natalensis species that will be investigated will not be its broad description, i.e. not 
including M. dracomantana and M. kraussii. 
1.6.2. Ethnobotany 
According to the case studies on the indigenous medicinal market by 
CUNNINGHAM (1988), and MANDER (1997), Scilla natalensis is ranked as the most 
popular plant species sold at the markets (Figure 1.1 C). MANDER (1997) reported that 
95.5 tonnes of S. natalensis bulbs are sold annually in the Durban medicinal plant 
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trade. In the Witwatersrand informal medicinal plant trade, S. natalensis is the second 
most commonly stocked medicinal plant after Artemisia afra (WILLIAMS 1996). 
1.6.3. Conservation 
Although S. natalensis is a popular bulbous plant, there are little supply 
constraints yet (MANDER 1997). Large populations still exist within KwaZulu-Natal. For 
this reason S. natalensis is still sold as the cheapest popular product per kg , in both the 
shop and street trade. They fetch a price of approximately R6.46/kg (MANDER 1997). 
However, this exploitation can only continue for so long. The demand is too high to be 
sustainable. SCOD-SHAW (1999) suggested that the conservation status of S. 
natalensis is vulnerable (Alacd, A2cd) , as it has been over-exploited over most of its 
distribution range. HILTON-TAYLOR (1996) rated S. natalensis' conservation status to 
be higher (K), stating that its exact population size in the wild was "insufficiently known". 
To alleviate pressures on the natural resources, some form of conservation needs to be 
implemented. McCARTAN and VAN STADEN (1998) successfully micropropagated S. 
nata/ensis plantlets in vitro. CUNNINGHAM (1988) suggested that if we assume that S. 
nata/ensis grows at the same rate and density as Urginea maritima (harvesting after 6 
years, 10 000 bulbs peracre), which were cultivated by GENTRY, VERBISCAR and 
BANIGAN (1987), then 3000 bags could be sold from 70 ha of land . This would 
alleviate over-exploitation from the wild . 
1.6.4. Medicinal Uses 
Merwilla natalensis (= Scilla natalensis) is known to the Zulu-speaking people of 
South Africa as inguduza , which means "searching the body for the cause of the 
ailment" (WILLIAMS 1996). The bulbs of M. natalensis are sold for the treatment of 
various ailments. These include gastro-intestinal ailments, which includes stomach 
aches, constipation, intestinal worms, diarrhoea, dysentery, nausea and indigestion 
(HUTCHINGS 1989). M. natalensis is also taken in the treatment of sprains and 
fractures, sores, boils and growths such as tumours, lumps or other swellings that may 
or may not be cancerous (PHILLIPS 1917; WAD and BREYER-BRANDWIJK 1962; 
HUTCHINGS 1989). There have also been reports that M. natalensis is used 
gynaecologically in the treatment of menstrual pains and to facilitate delivery during 
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pregnancy (GERSTNER 1941; HUTCHINGS 1989; HUTCHINGS, scon, LEWIS and 
CUNNINGHAM 1996). Decoctions are also taken as enemas for female fertilization 
and to enhance male potency and libido. M. natalensis has also been included in the 
treatment of chestpains and kidney troubles (ROTHWELL 1999). In most cases the 
bulbs are prepared as enemas and purgatives (GERSTNER 1938; 1939). 
1.6.5. Screenings Previously Performed 
JAGER, HUTCHINGS and VAN STADEN (1996) screened aqueous and 
ethanol extracts of M. natalensis for prostaglandin-synthesis inhibitors (prostaglandins 
are involved in the complex process of inflammation and are responsible for the 
sensation of pain). The result showed that aqueous extracts from M. natalensis bulbs 
only had low inhibition of prostaglandin-synthesis. Higher activity was displayed with 
the ethanol extracts. However, the activity was not as high as many of the other 
species that were also tested. 
Preliminary studies done by MAnHE (1988, 1989) indicated that extracts from 
S. natalensis have antimicrobial activity against a range of pus-forming organisms in 
vitro. RABE and VAN STADEN (1997) screened M. natalensis for in vitro antibacterial 
activity using the agar disc-diffusion assay (RASOANAIVO and RATSIMAMANGA-
URVERG 1993). No activity was reported against any of the five bacteria tested. 
Two homoisoflavanones have been isolated from M. natalensis. These are 5,7-
dihYdroXY-6-methoXY-3-( 4-hydroxybenzyl) chroman-4-one and 5,7 -dihydroxy-3-(3-
hydroxy-4-methoxybenzyl) chroman-4-one (CROUCH, BANGANI and MULHOLLAND 
1999). Homoisoflavanones have been reported in other Scilla species as well. DELLA 
LOGGIA, DEL NEGRO, TUBARO, BARONE and PARRILLI (1989) showed the 
homoisoflavanones of Muscari comosum to have anti-inflammatory activity. 
Homoisoflavanones have also been shown to have anti-allergenic, anti-histaminic, 
antimutagenic and angioprotective properties as well as being potent phosphodieterase 
inhibitors (AMSCHLER, FRAHM, HATZELMANN, KILIAN, MULLER-DOBLIES and 
MULLER-DOBLIES 1996). 
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Figure 1.1. (A) Merwilla natalensis plant in flower. (B) Inflorescence with a bee 
collecting pollen. (C) Bagged plant material being sold at a 
Pietermaritzburg traditional market. M. natalensis bulbs are one of the 
more commonly sold medicinal plants. (D) Distribution of M. natalensis in 
South Africa. (E) M. natalensis bulbs found in the Drakensberg. An 
antelope possibly ate the leaves, as spoor was found around the bulbs. 
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M. natalensis is also reported to possibly contain saponins (HUTCHINGS, 
SCOTT, LEWIS and CUNNINGHAM 1996). LOWER (1985) showed that saponins 
have potential antimicrobial, cytostatic and anti-inflammatory activity. 
KAMANO and PETIT (1974) reported the presence of cardiac glycosides in 
different Scilla species, but the presence of these glycosides in M. natalensis still 
needs to be demonstrated (VAN WYK, VAN OUDTSHOORN and GERICKE 1997). 
KELLERMAN, COETZER and NAUDE (1988) stated that electrocardiographic 
changes likened to those of cardiac glycoside poisoning were recorded in their work 
on M. natalensis. It is thought that M. natalensis may contain heart glycosides of the 
bufadienolide type, such as scillaren A. but no proof of this has been reported. 
Although the bulbs are thought to contain cardiac glycosides and are toxic to 
livestock (KELLERMAN, COETZER and NAUDE 1988), evidence found in the 
Drakensberg (Figure 1.1 E) indicates that the wild animals browse the leaves. 
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1.7. Aims 
The aims of this study were to firstly evaluate the rational usage of Merwilla 
natalensis as a medicinal plant and screen the bulbs for any phytochemical 
compounds that may have pharmacological activity. Secondly, analyse cultivated 
field trials of M. natalensis and develop a chemical fingerprinting system to use to 
analyse field-grown material. 
Due to the broad usage of M. natalensis as a medicinal plant, the first part of 
this study was to determine the pharmacological activity of this species. This 
involved in vitro testing of bulb extracts for antibacterial, anti-inflammatory, anti-
cancer, anti-viral, antischistosomal and anthelmintic activity. Once activity had been 
assessed, phytochemical screenings were performed to investigate for potentially 
active compounds. 
The second part of the study was aimed at analyzing material grown in field 
trials from two different climatic and geographic regions within South Africa. Analysis 
was to be conducted on growth, and pharmacological activity. A chemical 
fingerprinting system was to be developed and chemical fingerprinting analysis done 




PHARMACOLOGICAL INVESTIGATION OF 
MERWILLA NATALENSIS 
Over the last few years pharmacological investigations have been carried out on a 
number of commonly used medicinal plants to establish a scientific rationale for their 
usage in traditional medicine. This is very important not only to determine new 
possible drugs that are plant based but also to show that many of the medicinal 
plants used in traditional medicine do in fact have pharmacologically active 
properties. In many instances, traditional usage has been backed up with scientific 
data. 
There is also the need to determine whether certain plants that are being 
used are not toxic to humans. This is very important as the number of non-specialist 
gatherers and traditional healers increase. The potential for poisonings also 
increases as more people make use of traditional medicines. 
2.2. Collection and Preparation of Merwilla natalensis Bulb Material 
Mature (5-10 years old) healthy looking bulbs of Merwilla natalensis were 
collected from stock plants grown at the University of Natal Botanical Gardens. The 
bulbs were approximately 8 cm in diameter and on average had a fresh weight of ±400 
g (70 g dry weight). The bulbs were rinsed under tap water followed by distilled water 
before being cut into small pieces. The cut pieces were placed into paper bags and 
dried at 50°C for approximately 72 h. Once dry, the pieces of bulbs were ground into 
powders using a mill (Greiner Labortechnik). The powdered bulbs were placed into air-
tight containers and stored in the dark until extraction. 
Extracts were made using four solvents, ranging in polarity (water, methanol, 
dichloromethane and hexane). The extraction procedure consisted of sonicating 500 
mg of powdered M. natalensis bulb material in 5 ml extraction solvent for 30 min. 
The plant material was removed by filtering the extracts under vacuum through 
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Whatman No. 1 filter paper discs using a BOchner funnel. The filtered extracts were 
taken to dryness before being stored at 5°C. 
2.3. Antibacterial Screening 
2.3.1. Introduction 
Bacteria are amongst the most abundant organisms on earth and are able to 
adapt to almost any living condition. They are both useful and harmful to humans. 
Infections caused by bacteria are very common and frequently cause death. For this 
reason antibacterial drugs are among the most important therapeutic discoveries of the 
twentieth century (PAGE, CURTIS, SUDER, WALKER and HOFFMAN 1997). 
An increasing problem with antibiotics is the development of resistance by a 
variety of bacteria. Over-prescription and use of antibiotics have contributed 
significantly to antibiotic resistance (PAGE, CURTIS, SUTTER, WALKER and 
HOFFMAN 1997). LAURENCE and BENNETT (1980) recognized two types of drug 
resistance. The first type, and the most common, is drug tolerance. This occurs 
when the organism is capable of growing in the presence of the drug. The second is 
drug destroying, which is when the organisms inactivate the drug. PAGE, CURTIS, 
SUTTER, WALKER and HOFFMAN (1997) classified antibiotic resistance as being 
either innate or acquired. Innate resistance is based on the mechanism of the drug, 
while acquired resistance refers to the genetic resistance of the bacteria. According 
to PAGE, CURTIS, SUTTER, WALKER and HOFFMAN (1997) there is no antibiotic 
that does not experience acquired resistance. For this reason it is clear that new 
antibiotic drugs need to be developed on a continuous basis. 
Antibacterial activity of medicinal plant extracts has previously been evaluated 
using various methods, which are classified into three groups, i.e. disc-diffusion, 
dilution and bioautographic assays. There is no standardised method for expressing 
the results of antibacterial screening . Results can also be influenced by many 
factors, including the extraction method, inocula volume, culture medium 
composition, pH and incubation temperature (RIOS, RECIO and VILLAR 1988). The 
disc-diffusion assays allow several plant extracts to be screened against various 
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bacteria at the same time. This is suitable for preliminary screenings. The dilution 
assays are used to determine more precisely the antibacterial activity of extracts, 
giving the minimum inhibitory concentration (MIC) or minimum bactericidal 
concentration (MSC) values of test extracts for a given microorganism. The MIC 
value is the concentration that inhibits bacterial growth, while the MSC is the lowest 
concentration required to kill the bacterium. The MSC is often two to eight times that 
, 
of the MIC (PAGE, CURTIS, SUTTER, WALKER and HOFFMAN 1997). The 
bioautographic assays allows for rapid detection of bioactive constituents of plant 
extracts during bioassay-guided fractionation (RASOANAIVO and 
RATSIMAMANGA-URVERG 1993). 
Many South African plants have potential antibiotic activity. RASE and VAN 
STADEN (1997), ELOFF (1998), KELMANSON, JAGER and VAN STADEN (2000), 
and McGAW, JAGER and VAN STADEN (2000) have examined many South African 
plants that have potential antibacterial activity. RASE and VAN STADEN (1997) 
screened 21 different plant species at a concentration of 1 mg/ml against five of the 
more common bacteria that plague our lives. The plants selected were based on 
reported traditional treatment of symptoms such as wounds, boils and purulent 
sores. One of the species screened for in vitro antibacterial activity was M. 
natalensis (Scilla natalensis) . Methanol and aqueous extracts were screened using 
the disc-diffusion assay of RASOANAIVO and RATSIMAMANGA-URVERG (1993). 
S. natalensis bulb extracts showed no activity at concentrations of 1 mg/ml (RASE 
and VAN STADEN, 1997). Preliminary studies done by MATTHE (1988; 1989) 
indicated that extracts from S. natalensis have antimicrobial activity against a range of 
pus-forming organisms in vitro. 
2.3.2. Method of Screening 
2.3.2.1. Preparation of Extracts 
Fifty mg/ml of the plant extract residues were dissolved in 1 ml of water 
(aqueous extract), methanol (methanol extract) and acetone (dichloromethane and 
hexane extracts). Dichloromethane and hexane were toxic to the test bacteria. 
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2.3.2.2. Bacterial Strains Screened for Antibacterial Activity 
Each extract was bioassayed against two Gram-positive bacteria, Bacillus 
subtilis (ATCC No. 6051) and Staphylococcus aureus (ATCC No. 12600) and two 
Gram-negative bacteria Escherichia coli (ATCC No. 11775) and Klebsiella pneumoniae 
(ATCC No. 13883). The bacterial strains were obtained from the American Type 
Culture Collection (ATCC). The bacterial strains were maintained on Mueller-Hinton 
nutrient agar (Biolab) at 4°C. 
2.3.2.3. MIC Bioassay 
The bioassay used for antibacterial screening was the microdilution method for 
MIC determination as described by ELOFF (1998). Prior to use in the assay, 
suspension cultures were inoculated in Mueller-Hinton (MH) broth (Oxoid) from 
bacterial stock cultures and incubated overnight at 37°C in a waterbath with an orbital 
shaker. For each of the four bacteria, 100 1-11 of redissolved extract (50 mg/ml) were 
two-fold serially diluted with 100 1-11 sterile distilled water in a sterile 96-well microtitre 
plate (Greiner Labortechnik). A similar two-fold serial dilution of neomycin (Sigma) (100 
I-Ig/ml) was used as a positive control against each bacterium. Extraction solvents, 
extracts and bacteria-free controls were included as negative controls. The bacterial-
saturated suspension cultures were diluted 1: 100 with sterile MH broth, with 100 1-11 
being added to each of the wells containing the test and control solutions. The plates 
were covered and incubated overnight at 37°C. Bacterial growth was indicated by 
adding 40 1-11 of 0.2 mglml p-iodonitrotetrazolium chloride (Sigma) to each of the wells. 
The plates were incubated at 37°C for a further 30 min. Lack of antibacterial activity is 
indicated by a change in colour. The MIC was taken as the lowest concentration of 
plant extract to elicit an inhibitory effect on the growth (last well not to exhibit a colour 
change) of the test bacterium. 
2.3.3. Results and Discussion 
One of the uncertainties with this bioassay is that the recorded MIC values are 
possibly MBC values. It is uncertain whether the bacteria are actually killed by the 
extract at the given value, or at the low concentrations, do not cause a colour change 
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with the addition of the p-iodonitrotetrazolium chloride. Those wells that do exhibit a 
colour change may represent concentrations that do not inhibit growth , or their 
growth is inhibited, but the concentrations are not lethal to the test bacterium. The 
values taken are therefore recorded as MIC values (last well not to exhibit a colour 
change) as we know growth has been inhibited, but there is no certainty of 
bactericidal activity. 
Results for the general screening for antibacterial activity are shown in Table 1. 
No inhibitory activity was detected against the four test bacteria with the M. natalensis 
hexane extracts. Poor inhibitory activity was detected for both the water and 
dichloromethane extracts. The methanol extracts gave the highest inhibitory activity. 
The results suggest that the concentrations used by RASE and VAN STADEN (1997) 
were too low (1 mg/ml) to detect any antibacterial activity in the methanol extracts of M. 
natalensis (S. nata/ensis) bulbs. In the disc diffusion assay as used by RASE and VAN 
STADEN (1997) active compounds present in the extract diffuse through the bacteria 
inoculated agar, killing or inhibiting multiplication of the bacteria. If the compounds 
cannot diffuse readily through the agar, the extract is seen as being inactive. Therefore 
it is important to test extracts for antibacterial activity using the MIC assay as well. 
Table 2.1. Minimum inhibitory concentrations (MIC) of M. nata/ensis bulb extracts 
against four common bacterial types. Values with the same letter are not 







Bacteria 1 used (MIC (mg/ml)) 
E. c. K. p. B. s. 
6.3 c 6.3 c 12.5 d 
1.6 a 1.6 a 1.6 a 
3.1 b 6.3 c 6.3 c 
>12.5 e >12.5 e >12.5 e 






3.1 X 10-2 
lSacteria: E.c. = Escherichia coli, K.p. = Klebsiella pneumoniae, B.s. = Bacillus subtilis, S.a. = Staphylococcus aureus 
2Extract: dissolved in acetone 
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Extract concentration is important in terms of its traditional usage. At the wrong 
dosage, the plant extracts may not have any antibacterial activity. RABE and VAN 
STADEN (1997) reported that the methanol extracts of those plant species that 
exhibited antibacterial activity, had higher activity than the aqueous extracts. 
Generally no significant differences (p~0.05) were noted between the activity 
obtained against the Gram-positive or Gram-negative bacteria. The only extracts that 
showed any significant differences (p~0.05) in activity between the test bacteria were 
the aqueous and dichloromethane extracts which yielded significant differences for 
Bacillus subtilis and Escherichia coli respectively. Due to the outer membrane 
structure of Gram-negative bacteria, the effectiveness of a drug is somewhat 
challenging (PAGE, CURTIS, SUTTER, WALKER and HOFFMAN 1997). This is 
often the case with plant extracts as well. Plant extracts are usually more active 
against Gram-positive bacteria (McGAW, JAGER and VAN STADEN 2000). 
2.4. Anti-inflammatory Screening 
2.4.1. Introduction 
Inflammation is said to be a mechanism by which protective immune processes 
can be localized at a region where the infection occurs (VILLEE, SOLOMON, MARTIN, 
MARTIN, BERG and DAVIS 1989). Inflammation is a complex process with a number 
of different mediators, including prostaglandins (CAMPBELL 1990). Prostaglandins are 
responsible for the sensation of pain and inflammation. Prostaglandins are not stored in 
tissues for later release, but are biosynthesized within seconds of the activation of the 
appropriate enzymes and are rapidly metabolized (SMITH 1990). There are at least 14 
naturally occurring prostaglandins. Six are "primary" prostaglandins (PGE1, PGE2, 
PGE3, PGF1a, PGF2a and PGF3a) and give rise metabolically to another eight 
prostaglandins (LAURENCE and BENNETI 1980). The prostaglandin biosynthesis 
pathway begins with the conversion of arachidonic acid firstly, to prostaglandin G2 and 
then to prostaglandin GH2 (both are endoperoxide intermediates). These reactions are 
catalysed by the same enzyme, prostaglandin endoperoxide synthase. This enzyme 
consists of two components, cyclooxygenase and peroxidase. 
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Drugs that are developed for the treatment of pain and inflammation are 
targeted at inhibiting the cyclooxygenase enzyme and so prevent the formation of 
prostaglandins (NASIRI, HOl TH and BJORK 1993). Cyclooxygenase can be inhibited 
by three different mechanisms. These are: competitive inhibition, where there is 
reversible competition with arachidonate for binding to the cyclooxygenase site; 
mechanism based or time-dependent inactivation, where there is the formation of an 
enzyme-inhibitor complex; and non-competitive inhibition, where there is irreversible 
binding to the cyclooxygenase active site (SMITH and DEWln 1995). Drugs that have 
this pharmacological action are known as non-steroidal anti-inflammatory drugs 
(NSAID) (RANG and DALE 1987). Aspirin, an anti-inflammatory drug, was one of the 
first drugs discovered from medicinal plants (COX and BAlCK 1994). Other NSAIDs 
that are effective in the treatment of pain and inflammation are indomethacin, ibuprofen 
and paracetamol (RANG and DALE 1987). Recent investigations into the 
cyclooygenase enzyme have found thqt this enzyme actually consists of two isozymes, 
COX-1 and COX-2 (VANE 1994; HERSCHMANN 1996; VANE and BOniNG 1996). 
The COX-1 isozyme is constitutively expressed while the COX-2 isozyme seems to be 
induced during inflammation. According to VANE and BOniNG (1996) little or no 
COX-2 is found in resting cells. Nearly all NSAIDs that have been discovered are COX-
1 inhibitors, however all cyclooxygenase inhibitors seem to inhibit both the COX-1 and 
the COX-2 isozymes, but with different selectivity. The problem that exists is that many 
of the currently used anti-inflammatory drugs that are on the market have certain side 
effects which is why there is a growing need to discover new and improved drugs. 
HUTCHINGS (1989) listed many of the plants used in South Africa for the 
treatment of pain and inflammation. HUTCHINGS and VAN STADEN (1994) revised 
this list. However, no scientific evidence is given of the efficacy of these plants in 
treating inflammation. JAGER, HUTCHINGS and VAN STADEN (1996) screened 39 
Zulu medicinal plants for prostaglandin-synthesis inhibitors. Aqueous and ethanolic 
extracts of Scilla natalensis were included in the screening. The inhibition was low 
compared to many of the other species screened. McGAW, JAGER and VAN STADEN 
(1997) screened 26 plant used by Zulu healers for pain and inflammation for COX-1 
activity at concentrations of 50, 500 and 1000 ~g/ml. SHALE, STIRK and VAN 
STADEN (1999) screened 12 lesotho medicinal plants for prostaglandin-synthesis 
inhibitors. Six species were found to have above 90% inhibition at 200 ~g/ml. 
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2.4.2. Method of Screening 
2.4.2.1. Preparation of Extracts 
The dried extract residues were dissolved in water (aqueous extract) and 
ethanol (methanol, dichloromethane and hexane extracts). The methanol, 
dichloromethane and hexane residues were dissolved to 10 mg/ml ethanol, and the 
water residues to 2.5 mg/ml. 
2.4.2.2. COX-1 Enzyme Preparation 
Cyclooxygenase was obtained from sheep seminal vesicle microsomal 
fractions. Sheep seminal vesicles were homogenized at 4°C in potassium phosphate 
buffer with 1 mM EDT A. The homogenate was centrifuged at 4 000 g for 15 min (Avanti 
J-251 Centrifuge) to remove cell debris. The supernatant was recentrifuged at 17 000 g 
for 10 min to remove the mitocondria. Microsomes were isolated from the supernatant 
by centrifuging at 100 000 g for 1 h (Beckman L7-5S Centrifuge). The microsomal 
pellet was resuspended in 0.1 M potassium phosphate buffer (pH 7.4). The 
concentration of the enzyme was determined using the Bio-Rad Protein Assay Kit. 
Aliquots of 1 0 ~I microsome suspensions (0.3 ~g protein) were pipetted into Eppendorf 
tubes and stored at -70°C. 
2.4.2.3. COX-1 Bioassay 
The assay was performed as described by JAGER, HUTCHINGS and VAN 
STADEN (1996). The COX-1 enzyme (10 ~I) was activated with 50 ~I of co-factor 
solution on ice for 15 min. The co-factor solution consisted of 0.3 mg/ml L-epinephrine 
and 0.3 mg/ml reduced glutathione in 0.1 M tris buffer, pH 8.2. Sixty ~I of the enzymel 
co-factor solution were added to 20 ~I of sample (20 ~I of aqueous plant extracts, 2.5 ~I 
ethanolic plant extract + 17.5 ~I water or 2.5 ~I indomethacin standard (20 mM) + 17.5 
~I water). Extracts were tested at a final concentration of 250 ~g/ml. Twenty ~I of C4C] 
arachidonic acid (16 Ci/mol, 30 ~M) were added to each sample and the assay mixture 
was incubated at 37°C for 10 min. The reaction was terminated by adding 1 0 ~I of 2N 
HCI. A background (2.5 ~I ethanol + 17.5 ~I water) was kept in the ice bucket. After 
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incubation 41-11 of a 0.2 mg/ml carrier solution of unlabelled prostaglandins (PGE2:PGF2 
1 : 1 v/v) were added. 
The 14C-labelled prostaglandins synthesised during the assay were separated 
from the unmetabolized [14C] arachidonic acid by column chromatography. Silica gel in 
eluent 1 (hexane:dioxane:acetic acid 350:50: 1 v/v/v) was packed to a height of 3 cm in 
Pasteur pipettes. One ml of eluent 1 was added to each of the assay mixtures and this 
mixture was applied to the separate columns. The arachidonic acid was eluted from the 
column with 4 ml of eluent 1 and discarded. The labelled prostaglandins were 
subsequently eluted with 3 ml of eluent 2 (ethyl acetate: methanol 85:15 v:v) into 
scintillation vials. Four ml of scintillation fluid were added to each vial and the 
radioactivity measured using a Beckman LS 6000LL scintillation counter. The 
percentage inhibition of the test solutions was calculated by comparing the amount of 
radioactivity present in the samples to that in the solvent blank, using the following 
formula: 
radioactivitysample - radioactivitYbackgroUnd 
Inhibition (%) = 1 - ----------------------------------------------------- x 100 
radioactivityblank - radioactivitybackgrOUnd 
The same formula was applied to the indomethacin standard to determine the validity 
of the assay-system. Extracts were assayed in duplicate. 
2.4.2.4. COX-2 Bioassay 
The cyclooxygenase-2 (COX-2) assay was performed as described by 
NOREEN, RINGBOM, PERERA, DANIELSON and BOHLIN (1998) with slight 
modifications (ZSCHOCKE and VAN STADEN 2000). The assay follows the same 
protocol as the COX-1 assay. The purified COX-2 enzyme however, was obtained from 
sheep placental cotyledons, purchased from Cayman Chemicals. The enzyme (10 1-11) 
was activated with 50 1-11 cofactor solution (0.9 mM L-epinephrine, 0.49 mM glutathione 
and 1 I-IM hematin in 0.1 M Tris buffer, at pH of 8). This was done on ice for 5 min. The 
enzyme solution (60 1-11) and the sample solutions (2.5 1-11 dissolved plant extract applied 
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to 17.5 IJI distilled water) were incubated for 5 min at room temperature. Extracts were 
tested at a final concentration of 250 IJg/ml. The reaction was started with the addition 
of 20 IJI C4C] arachidonic acid (16 Ci/mol, 30 IJM) to each of the samples. The samples 
were incubated for 10 min at 37°C before the reaction was terminated by adding 10 IJI 
of 2N HC\. Four IJI of a 0.2 mg/ml carrier solution of unlabelled prostaglandins 
(PGE2:PGF2 1:1 v/v) were added. COX-2 inhibition was determined as described for 
the COX-1 assay. 
2.4.3. Results and Discussion 
Both the COX-1 and the COX-2 assays follow the same protocol, which 
facilitates comparisons between activities of the extracts on the two enzymes 
(ZSCHOCKE and VAN STADEN 2000). The results were recorded as the mean 
percentage inhibition by the extracts of the enzymes cyclooxygenase-1 and 
cyclooxygenase-2 (Figure 2.1). Results for the COX-1 inhibition assay showed the 
aqueous and methanol extracts to have significantly lower activity. JAGER, 
HUTCHINGS and VAN STADEN (1996) reported 81% inhibition by the ethanolic S. 
nata/ensis extracts against COX-1. However, the extracts were screened at a final 
concentration of 500 g/ml which is double the concentration used in this study. This 
would explain the difference in the results of these screenings. Only the lipophilic 
extracts showed significantly high levels of anti-inflammatory activity, with 80 and 71 % 
inhibition for the dichlorormethane and hexane extracts respectively. Similar results 
were obtained with the COX-2 inhibition. Dichloromethane gave 91 % inhibition, which 
was significantly higher (p:::0.05) than the other extracts. Hexane gave 82% inhibition to 
the COX-2 enzyme. No significant differences (p:::0.05) were found between the more 
polar extracts (water and methanol) which both have very low inhibition. The 
indomethacin controls were 54% and 60% inhibition for COX-1 and COX-2 
respectively. Polar solvents are known to extract compounds that may interfere in the 
enzyme-based bioassays. Lipophilic compounds, which are extracted with the non-
polar solvents are most likely present in the polar solvent extracts as well, though at 
very low concentrations. If one considers that lipophilic compounds have better 
absorption through the cell membrane, having good inhibition of both COX-1 and COX-
2 by the dichloromethane extracts is highly desirable. 
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Water MeOH oeM Hexane 
Extraction Solvent 
Figure 2.1 . Percentage inhibition of M. nata/ensis extracts (250 J,Jg/ml) against 
prostaglandin synthesis by (A) COX-1 and (8) COX-2 enzymes. Values 
within the same graph with the same letter are not significantly different 
(at 5% level of significance) from each other. OCM = dichloromethane. 
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In general plant material extracted with ethanol shows higher inhibitory activity 
than plant material extracted with water (McGAW, JAGER and VAN STADEN 1997, 
LINDSEY, JAGER, RAIDOO and VAN STADEN 1999). Although water is the most 
commonly used solvent, ethanol is also available to many traditional healers. Solvents 
like hexane and dichloromethane, which showed the highest percentage inhibition, are 
not easily available to the majority of traditional healers. As these solvents are toxic, if 
they were made available to the healers, extracts made with them would have to be 
dried down to remove the dichloromethane and hexane. The dried residues could be 
administered in the form of a powder or redissolved in an ethanol solution. However, 
these solvents may also extract other compounds in higher concentrations, causing the 
crude extracts to be toxic. Dosage is important with regard to which solvent is being 
used. With aqueous solvents, the dosage would have to be higher, however, this may 
then increase the toxicity as the concentration of possible toxic polar compounds 
increases. The same dosage using a dichloromethane extraction may be potentially 
dangerous. 
2.5. Antischistosomal Screening 
2.5.1. Introduction 
Schistosomiasis, commonly known as "bilharziasis", is an important health issue 
in Third World countries found in the tropics and subtropics. It is estimated that over 
200 million people in 73 countries are infected with the disease (McCULLOUGH and 
MOTT 1983), while a further 4-5% of the worlds population are at risk of being infected 
(BASCH 1991; BROWN 1994). Most of these people live in rural communities that are 
situated near or around slow-moving water sources. The most extensively infected 
areas are found in Africa, China and the neotropics. According to BROWN (1994) the 
spreading of schistosomiasis is aided by the creation of suitable habitats for the host 
snails and the travelling of infected people. 
Schistosomiasis is a parasitic infection that is caused by blood-flukes which are 
a type of trematode of the genus Schistosoma. There are 11 different Schistosoma 
species worldwide (BASCH 1991), with three of these species residing in South Africa 
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(PITCHFORD 1980; VAN WYK 1983). These are Schistosoma haematobium (causes 
urinary bilharzia), Schistosoma mansoni (causes intestinal bilharzia), and Schistosoma 
mattheei (primarily found in domestic livestock). 
The adult worms live in the abdominal blood system of their mammalian hosts, 
situated in the veins associated with the intestine or those around the bladder. The 
adult worms are dioecious, and produce non-operate eggs, which are laid in the blood 
vessels of their host. Each egg contains a miracidium larva, which hatches only when 
the egg comes in contact with water. The miracidia are ciliated and capable of 
swimming. They can only survive for 48 h if an intermediate host snail is not found. 
Many of the Schistosoma species are intermediate host specific. This means that they 
are only compatible with a particular snail species. This compatibility is thought to be 
associated with genetically-based variations found in the snails and the Schistosoma 
species. Once a compatible host is located, the miracidia penetrate the snail's 
epithelium with the aid of histolytic secretions (BROWN 1994). Through a series of 
transformations, cercariae emerge from the snail's mantle collar and pseudobranch 
(PAN 1965). If the compatibility between the host and parasite is good, then there is a 
high rate of infection, with many cercariae being shed soon after penetration (BROWN 
1994). The cercariae are also motile and have to find a compatible mammalian host 
within 48 h. Once a host has been located, the cercariae penetrates the skin and in so 
doing loses its tail and transforms into a schistosomula worm before entering into the 
blood stream of the host (STURROCK 1993). 
Most research into controlling schistosomiasis has been done on developing 
molluscicides from South African plants (BRACKENBURY, APPLETON and 
THURMAN 1996; CLARK and APPLETON 1996; CLARK, APPLETON and DREWES 
1996; BRACKENBURY and APPLETON 1997; BRACKENBURY, APPLETON and 
KAYONGA 1997; CLARK, APPLETON and KVALSVIG 1997). More resent studies 
have focussed on possible use of medicinal plants to treat the disease at the human 
stage of the cycle. SPARG, VAN STADEN and JAGER (2000) and M0LGAARD, 
NIELSEN, RASMUSSEN, DRUMMOND, MAKAZA and ANDREASSEN (2001) 
investigated the use of southern African plant species to treat schistosomiasis in vitro. 
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2.5.2. Method of Screening 
2.5.2 .1. Preparation of Extracts 
The aqueous residues were dissolved to 50 mg/ml with distilled water. Fresh M. 
natalensis bulbs were also macerated and extracted with distilled water. The residues 
were dissolved to 50 mg/ml. 
2.5.2.2. Collection and Storage of Snails 
Bulinus africanus (Krauss) snails were collected from the Siangspruit at 
Campsdrift, Pietermaritzburg. Snails were identified and confirmed with specimens 
housed at the Pietermaritzburg Museum. The snails were housed in tanks, which were 
kept under controlled conditions of aeration, 12 h light and 25 ± 2°C. The snails were 
fed on freeze-dried lettuce. The snails were kept for up to 4 weeks. 
2.5.2.3. In vitro Bioassay 
The antischistosomiasis bioassay as described by SPARG, VAN STADEN and 
JAGER (2000) was used in the screening. Infected Bulinus africanus snails were 
placed into test tubes under a 60 watt electric lamp to promote the shedding of 
Schistosoma haematobium cercariae. The cercariae were collected and subjected to a 
shearing stress using a syringe with a 0.8 ml needle attached. The sheering procedure 
was repeated approximately five times, causing the cercariae to lose their tails and 
thereby transforming them into schistosomula worms. The bioassay was run in 
microtiter plates. The culture medium (100 1-11) was placed into each well. The extracts 
(100 1-11) were placed into the first well from which two-fold serial dilutions were made. 
Four schistosomula worms along with 100 1-11 culture medium were pipetted into each of 
the wells containing the extract dilutions. The bioassay was incubated at 25°C for 1 h 
after which each well was examined to see how many of the schistosomula had 
survived and the fatal concentration calculated. The assay was repeated three times 
for each extract. Praziquantel (Sigma) and a culture medium blank were used as 
controls. 
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2.5 .2.4. Culture Medium 
The culture medium used was the mineral salt component of Roswell Park 
Memorial Institute (RPM I) 1640 media (NaGI 6 gil; KGI 400 mgll; Ga(N03h-4H20 100 
mgll; MgS04·7H20 100 mgll; Na2HP04·12H20 2.02 gil ; and NaHG03 2 gil) (BUTLER 
1992), supplemented with 5% bovine calf serum. 
2.5.3. Results and Discussion 
The results of the screening for antischistosomal activity are shown in Table 2. 
The praziquantel (Sigma) control was lethal at a concentration of 0.001 mg/ml. 
Aqueous extracts from both fresh and dry bulb material of M. natalensis had high 
activity. The results show the activity to be higher than any of the plants screened 
previously for antischistosomic activity using this assay (SPARG, VAN STADEN and 
JAGER 2000; M0LGAARD, NIELSEN, RASMUSSEN, DRUMMOND, MAKAZA and 
ANDREASSEN 2001). Abrus precatorius root extracts had the highest activity with a 
lethal concentration of 0.6 mg/ml (M0LGAARD, NIELSEN, RASMUSSEN, 
DRUMMOND, MAKAZA and ANDREASSEN 2001). M. natalensis bulb extracts were 
lethal to S. haematobium at 0.4 mg/ml. However, there is no report of M. natalensis 
being used traditionally for the treatment of schistosomiasis. The presence of saponins, 
which have potential molluscicidal activity combined with antischistosomal activity, 
would make M. natalensis very useful in controlling schistosomiasis in many of the rural 
communities where this disease has its biggest threat. 
Table 2.2. Lethal concentrations (LC) of aqueous M. nata/ensis extracts against 
schistosomula of the species Schistosoma haematobium 
Type of material LC against schistosomula (mg/ml) 
Fresh bulb 0.4 
Dry bulb 0.4 
27 
CHAPTER 2 PHARMACOLOGICAL INVESTIGATION OFMERWILLA NATALENSIS 
2.6. Anthelmintic Screening 
2.6.1. Introduction 
Helminthiasis is a disease that is characterized by the presence of parasitic 
worms in the body. The intestines of humans and their domestic animals are infected 
with several types of worms. The most important types are nematodes or round worms. 
Most nematodes are free-living, but many species are parasitic on insects, fish, birds, 
fungi, plants or animals including man. Basically, they have been found to occur in 
almost every type of environment found on the planet (LEE 1965). Most of the 
nematodes and other worms that live in the intestines of man do little to impair the 
health of their hosts. Symptoms of their presence usually only appear in cases of heavy 
infestation (LEWIS and ELVIN-LEWIS 1977). 
Helminthiasis is controlled by chemotherapy using broad spectrum anthelmintics 
(NJOKU, OKEYODE and ASUZU 1996). The more commonly used anthelmintics 
include the benzimidazoles (albendazole and thiabendazole) and the non-
benzimidazoles (Ievamisole, pyrantel and avermectin) (SIMPKIM and COLES 1981). 
However, problems do exist with these drugs. Continued usage can result in the 
development of resistance, while some of the synthetic drugs used are expensive and 
not always readily available (ASUZU and NJOKU 1996). There is an urgent need for 
new, inexpensive drugs that will not allow for easy resistance to develop. Much effort is 
being made to discover new anthelmintic drugs that are of plant origin (NJOKU, 
OKEYODE and ASUZU 1996). Anthelmintic drugs must have a wide margin of safety 
between its toxicity to the worms and its toxicity to the host. LEWIS and ELVIN-LEWIS 
(1977) stated that the anthelmintic properties of many naturally occurring products have 
been known since the dawn of civilizations and are still in use today. ASUZU and 
NJOKU (1996) believe that medicinal plants may be the most important source of new 
anthelmintic drugs. 
SIMPKIN and COLES (1981) reviewed a number of in vitro test systems that 
have been used to test against different nematode species. Caenorhabditis e/egans 
has unofficially been adopted as a convenient model to study important problems in the 
developmental genetics and biology of metazoans (BRENNER 1974). SIMPKIN and 
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COLE (1981) recommend using free-living nematodes for screening anthelmintic 
compounds. Screenings could be quite simple and would not require sophisticated 
equipment. SIMPKIN and COLES (1981) suggested that C. elegans be used in in vitro 
assays to screen for potential anthelmintics. McGAW, JAGER and VAN STADEN 
(2000) successfully screened 24 South African medicinal plants using an in vitro 
bioassay involving the free-living nematode C. elegans. 
2.6.2. Method of Screening 
2.6.2.1 . Preparation of Extracts 
The aqueous, methanol, dichloromethane and hexane extract residues were 
dissolved to 100 mg/ml. The dichloromethane and hexane extracts were dissolved in 
acetone. 
2.6.2.2. In Vitro Bioassay 
The nematode Caenorhabditis elegans var. Bristol (N2) was cultured on 
nematode growth agar seeded with E. coli according to the method of BRENNER 
(1974). The anthelmintic assay used was the method of RASOANAIVO and 
RATSIMAMANGA-URVERG (1993) as described by McGAW, JAGER and VAN 
STADEN (2000). Extract solutions were prepared (5 1-11 dissolved extract + 495 1-11 
distilled water) to which 10 1-11 M9 buffer (BRENNER 1974) containing approximately 
100 nematodes from 7-10 day old cultures were added. The samples were incubated 
for 2 h at 25°C in the dark. A standard concentration of levamisole (Sigma) (5 I-Iglml = 
2.5 1-11 of 1 mglmllevamisole solution + 497.5 1-11 distilled water) was used as a positive 
control. Solvent blanks and a buffer only solution were included as negative controls. 
Using a dissecting microscope, the percentage of nematodes still alive was estimated, 
and their movement noted and compared to the controls. 
2.6.3. Results and Discussion 
The anthelmintic assay used is a cheap and simple assay that can be used to 
test for anthelmintic activity. Methanol extracts of M. natalensis showed good activity, 
29 
CHAPTER 2 PHARMACOLOGICAL INVESTIGATION OFMERWlLLA NATALENSIS 
killing approximately 47% of the nematodes in the anthelmintic assay (Figure 2.2) , with 
the remaining 53% moving slower than those of the negative control. Both the 
dichloromethane and the hexane extracts were significantly less active (p!50.05) killing 
approximately 28% of the nematodes while the water extracts killed only 22% of the 
nematodes. The levamisole control (5 IJg/ml) killed approximately 40% of the 
nematodes. 
McGAW, JAGER and VAN STADEN (2000) found that the aqueous extracts 
were generally more active than the ethanolic extracts. Hexane extracts were found to 
have low activity as well. The results from this study with M. natalensis extracts showed 
that both the methanol and the hexane extracts had higher activity against C. elegans 
than the aqueous extracts. From the results it would seem that there are both polar and 
non-polar compounds with anthelmintic activity in the bulbs of M. natalensis. 
100 a 














Blank Levamisole Water MeOH OeM Hexane 
Extraction Solvent 
Figure 2.2. Mean percentage of Caenorhabditis eJegans nematodes alive after being 
exposed to M. nataJensis extracts for two hours. Values within the same 
graph with the same letter are not significantly different (at 5% level of 
significance) from each other. OeM = dichloromethane. 
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Merwilla natalensis is used traditionally to treat intestinal worms (HUTCHINGS 
1989). Ethanol is used sometimes by traditional healers for extraction therefore the 
healers could obtain similar anthelmintic activity. However, possible oral application of 
such ethanol extracts would be highly dangerous if not fatal if administered to children, 
who often have the highest worm-load. Residues of ethanol or methanol extracts 
should be dissolved in water before administration or possibly taken in powder form. 
2.7. Anticancer (DNA-damaging) Screening 
2.7.1. Introduction 
One of the dreaded illnesses that plague humans and animals is cancer. There 
are many forms, affecting different organs and parts of the body. In most cases, 
cancers are treated with anticancer drugs and chemotherapy. Although Western drugs 
are still used, research has focussed on discovering new potential anticancer 
compounds from indigenous medicinal sources. To date, large numbers of higher 
plants have been tested for anticancer properties and have yielded some positive 
results. The National Cancer Institute (NCI) have screened over 120 000 extracts from 
35 000 plant species for novel anticancer agents over a period of 25 years and have 
made some promiSing discoveries (SPJUT 1985). Two successes are: taxol (Taxus 
brevifolia Nutt.) which is used to treat breast, lung and neck cancer (CRAGG 1998) and 
the drug alkaloids vinblastine and vincristine which are both from the Madagascan rosy 
periwinkle (Catharanthus rose us) and are used in treating leukaemia. 
Many of the natural products that have demonstrated clinical utility as cancer 
chemotherapeutic agents, function by causing DNA damage in tumor cells (DEMAIN 
and SOLOMON 1986). Most of the detection systems have been developed 
specifically to find compounds with this mechanism of action. One such system is the 
biochemical induction assay (BIA) that was developed for the screening of anticancer 
drugs (ELESPURU and WHITE 1983). This assay is a simple, sensitive and rapid 
method, which has been successfully employed in the screening of microbial culture 
broths for anticancer agents (DEMAIN and SOLOMON 1986). The BIA is a 
modification on the lambda (J...) prophage induction assay, where DNA damage 
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releases A prophage from its latent, repressed state in an Escherichia coli lysogen. Any 
complete virus particles that are formed when DNA damage occurs can be assessed in 
an overnight plaque assay (HEILEMANN and HOWARD 1964; PRICE, BUCK and 
LEIN 1964). Instead of virus particle, DNA damage is assessed in the BIA by the 
formation of the enzyme p-galactosidase. In the BIA, the A lysogenic indicator is a 
special E. coli BR 513 strain (ATCC 33312) (WHITE, MAIESE and GREENSTEIN 
1986). 
2.7.2. Method of Screening 
2.7.2.1. Preparation of Extracts 
The dried M. natalensis extracts were re-dissolved to 100 mg/ml in their 
appropriate solvents. The dissolved extracts (10 1-11) were applied to sterile filter paper 
discs, which were placed onto agar assay plates. 
2.7.2.2. Preparation of the Base Layer 
Agar base layers were prepared using Nunc bioassay plates (243 mm x 243 
mm x 5 mm) dispensed with 100 ml LBE-amp agar and allowed to set. The LBE-amp 
agar was made up of 15 g LBE-amp agar in 1000 ml LBE medium (Tryptone 10g; 
yeast extract 5 g; NaCI 10 g; 1 M Tris 5 ml; distilled water 995 ml), autoclaved and 
allowed to cool to 50°C before adding 4 ml salt medium (distilled water 670 ml; 
MgS04·7H20 10 g; K2HP04 500 g; Na(NH4)HP04 -4H20 175 g; citric acid·H20 100 g), 
10 ml 20% glucose and 1 ml of 10 mg/ml sodium ampicillin solution. 
2.7.2.3. Preparation of Inoculum 
The test bacteria E. coli BR 513 (ATCC 33312) were grown overnight in 5 ml 
LBE broth at 37°C under constant agitation. The culture (0.7 ml) was diluted into 35 ml 
LBE broth supplemented with 0.5 ml 20% glucose (filter sterilized through a 0.22 I-Im 
filter) and 0.2 ml of a salt medium (MgS04·7H2014.9 gil; K2HP04 746.3 gil; 
Na(NH4)HP04-4H20 261.2 gil; citric acid·H20 149.3 gil). The diluted solution was 
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agitated at 37°C until an 00600 of 0.4 was reached . The solution was then centrifuged 
for 10 min at 5000 rpm (3000 x g). The supernatant was discarded and the pellet 
resuspended in 2 ml cold, sterile distilled water to give the inoculum. 
2.7.2.4. Preparation of the Assay Plates 
The inoculum was added to 75 ml 1 % soft agar (±50°C) and poured evenly over 
a prewarmed (37°C) base layer before being allowed to solidify for 10 min at room 
temperature. 
2.7.2.5. Biochemical Induction Assay (BIA) 
The dissolved extracts (10 J,JI) were loaded onto sterile Whatman No. 1 filter-
paper discs (6 mm) before being placed onto the assay plates. 4-Nitroquinoline-1-oxide 
(100, 50 and 5 J,Jg/ml) was used as a positive control. Solvent controls were also 
included. The assay plates were incubated at 37°C for 5 h before pouring over a 1 % 
soft agar substrate containing 120 mg fast blue RR and 20 mg 6-bromo-2-naphthyl-~­
galactosidase dissolved in 2 ml dimethyl sulfoxide. The plates were examined after 15 
min for the development of red-violet zones at the sites of sample application. The 
presence of a red-violet zone indicates positive anticancer activity. 
2.7.3 . Results and Discussion 
Clear red-violet zones of activity were observed around the positive controls, but 
no colour changes were observed for the M. natalensis extracts. This however, does 
not indicate that there is no potential anticancer activity found in M. natalensis. One of 
the problems with this assay is that there is no guarantee that active compounds found 
in the extracts can diffuse through the agar. If this was the case, then no colour zone 
would be detected. Crude extracts of M. natalensis may also contain other compounds 
that either mask the active compounds by binding to them, so rendering them inactive. 
According to ELESPURU and WHITE (1983) the anticancer drug vinblastine, which is 
known to interfere with DNA, also showed no activity with this assay. Therefore, this 
assay may not be ideally suited for anticancer screening. 
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2.8. Cytotoxicity Testing 
2.8.1. Introduction 
Though many plants are used medicinally in the treatment of almost every 
ailment that affects humans and animals, many are highly cytotoxic to human and 
animal cells. However, this toxicity is not always a negative one. Plants that are 
cytotoxic have been used and are still investigated to treat tumor cells. 
Hundreds, if not thousands, of plant constituents have been found to be 
cytotoxic against one or more tumor cells in culture. However, not all classes of 
cytotoxic compounds have useful antitumor activity (CORDELL, FARNSWORTH, 
BEECHER, SOEJARTO, KINGHORN, PEZZUTO, WALL, WANI, BROWN, ONEILL, 
LEWIS, TAIT and HARRIS 1993). Cytotoxicity is extremely important when novel plant 
drugs are being investigated, especially if these drugs are to be taken orally for internal 
ailments. 
2.8.2. Method of Testing 
The cytotoxicity testing was performed by the Department of Medical Virology, 
Institute of Pathology, University of Pretoria, South Africa. Extracts of M. natalensis 
were tested for cytotoxicity by exposing monolayers of secondary vervet monkey 
kidney (VK) cells to dilutions of the filter sterilised (0.45 ~m membrane) plant extracts. 
Serial two-fold dilutions of the plant extracts, in serum-free Eagle's minimum essential 
medium (MEM) (National Institute for Virology, Johannesburg, South Africa), from a 
concentration of 3.9 ~g/ml to 1 000 ~g/ml, were used for testing on 24-hour-old 
monolayers of VK cells. The cells were monitored visually, by light microscopy, over a 
period of seven days and on the seventh day tested for cytotoxicity using a tetrazolium 
salt reduction (MIT) assay (VAN RENSBURG, ANDERSON, MYER JOONE and 
O'SULLIVAN 1994), based on the method of HUSSAIN, NOURI and OLIVER (1993). 
Monolayers of cells exposed to serum-free MEM alone were used as a control. 
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2.8.3. Results and Discussion 
Visual examination of the monolayers of VK cells treated with the M. natalensis 
extract, from 3.9 ~g/ml up to 1 000 ~g/ml, showed gross morphological changes and 
cell death, suggestive of severe cytotoxicity, at all concentrations tested (Table 2.3). 
Table 2.3. Survival of secondary vervet monkey kidney (VK) cells in the presence 
of varying concentrations of aqueous extracts of M. nata/ensis. 
Extract Concentration Percentage survival of 










These observations were confirmed by the MIT assay. This high level of 
cytotoxicity could possibly account for the use of this species in the treatment of tumors 
by traditional healers. However, such a high level of cytotoxicity could be dangerous 
and may not even have any antitumor activity. These levels of toxicity are cause for 
concern since M. natalensis is one of most commonly sold medicinal plants at 
traditional medicine markets. The toxicity is most likely attributed to the presence of 
saponins. 
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2.9. Summary 
• Four solvent extracts were made from Merwilla natalensis bulbs. Solvents 
ranged in polarity (water, methanol, dichloromethane, hexane). 
• All four extracts were screened for antibacterial, anti-inflammatory, anthelmintic 
and DNA-damaging activity. Aqueous extracts were also screened for 
antischistosomal activity and cytotoxicity. 
• Methanol extracts had both the highest antibacterial and anthelmintic activity. 
• Methanol extracts were significantly more effective (p:50.05) than other solvent 
extracts against both Gram-positive and Gram-negative test bacteria (MIG = 1.6 
mg/ml). 
• Approximately 47% of the Caenorhabditis elegans nematodes were killed after 
being exposed for 2 h to the methanol extracts (concentration of 1 mg/ml). 
• Non-polar extracts had higher anti-inflammatory activity. Dichloromethane 
extracts gave the highest inhibitory effect on prostaglandin synthesis by both 
GOX-1 and GOX-2 enzymes (80 and 91% inhibition respectively at a 
concentration of 250 J,lg/ml). 
• Aqueous extracts of both fresh and dry material tested against Schistosoma 
haematobium gave very high activity. The crude extracts were lethal at a 
concentration of 0.4 mg/ml. 
• All the extracts showed no DNA-damaging activity at 100 mg/ml. 
• Aqueous extracts were highly cytotoxic, even at very low concentrations, which 
suggests that extracts could possibly have antitumor properties. 
• Results show that the bulbs of M. natalensis have a range of pharmacological 
activities, which might rationalise its popularity and use as a medicinal plant. 
36 
CHAPTER 3 PHYTOCHEMICAL SCREENING 
3.1. Saponins 
3.1.1. Introduction 
Saponins are a large group of glycosides, which are ubiquitous in plants. 
Their surface-active properties are what distinguish these compounds from others. 
They dissolve in water to form foamy solutions. These saponin-containing plants are 
sought after for use in household detergents. One such example is the soapwort 
(Saponaria officinalis L.), which has been widely used for centuries. Most saponins 
have haemolytic properties and are toxic to most cold-blooded animals. However, 
since these properties are not common to all saponins, they cannot be identified 
from other compounds on the basis of these properties (BRUNETON 1995). 
Saponins have been sought after in the pharmaceutical industry because some form 
the starting materials for the semi-synthesis of steroidal drugs. They also have 
pharmacological properties and are used in phytotherapy and in the cosmetic 
industry. 
Saponins can be classified into two groups based on the nature of their 
aglycone. The first group consists of the steroidal saponins, which are almost 
exclusively present in the monocotyledonous angiosperms. The second group 
consists of the triterpenoid saponins, which are the most common and occur mainly 
in the dicotyledonous angiosperms (BRUNETON 1995). Some authors distinguish a 
third group called steroidal amines, which are classified by others as steroidal 
alkaloids (BRUNETON 1995). 
Saponins have the ability to rupture erythrocytes. This has lead to the 
development of haemolytic assays for detecting the presence of saponins in drugs or 
plant extracts. The haemolytic properties are generally attributed to the interaction 
between the saponins and the sterols of the erythrocyte membrane. As a result, 
there is an increase in permeability and a loss of haemoglobin . Although toxic to 
cold-blooded species, if taken orally by warm-blooded species, saponins have only 
weak toxicity (BRUNETON 1995), which is probably attributed to low absorption 
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rates. The toxicity towards cold-blooded species has lead to the use of saponin-
containing drugs to catch fish . Saponins are also highly toxic to molluscs and have 
been investigated as molluscicides in the control of schistosomiasis (MARSTON and 
HOSTETTMANN 1985; MOTT 1987; ABDEL-GAWAD, EL-SAYED and ABDEL-
HAMEED 1999). More than 1000 plant species have been tested for molluscicidal 
activity (KLOOS and McCULLOUGH 1982). Molluscs, in particular Bulinus and 
Biomphalaria species, act as intermediate hosts in the life cycle of schistosomes. 
Many trials have been run in African countries, where the occurrence of 
schistosomiasis is very prevalent. Phytolacca dodecandra berries contain saponins 
with highly potent molluscicidal activity (LEMMA, HEYNEMAN and SILANGWA 
1984). Another species that has potent saponins is Swarizia madagascariensis 
(BOREL and HOSTETTMANN 1987). Field trial performed in Tanzania with S. 
madagascariensis, was very successful in reducing the densities of aquatic snails 
(SUTER, TANNER, BOREL, HOSTETTMANN and FREYVOGEL 1986). 
Saponins also have anti-inflammatory activity (HILLER 1987; L1, LEE, KANG, 
HYUN and WHANG 2002; KWAK, HAN, CHANG, KIM, KANG and SON 2003). 
Many saponins isolated from plant sources produce an inhibition of inflammation of 
carrageenin-induced edema. WOO, SHIN and KANG (1976) and WOO, KANG, 
WAGNER, SELIGMANN and CHARI (1978) showed that the saponins from different 
Phyto/acca species had anti-inflammatory activity. Many different species of the 
genus Phyto/acca contain saponins that have antifungal activity (MORENO and 
RODRIGUEZ 1981; KOBAYASHI, KOHTATSU and KAJIYAMA 1995; QUIROGA, 
SAMPIETRO and VATTUONE 2001; ESCALANTE, SANTECCHIA, LOPEZ, 
GATTUSO, GUTIERREZ RAVELO, DELLE MONACHE, GONZALEZ SIERRA and 
ZACCHINO 2001). Triterpenoid saponins from Chenopodium quinoa have been 
reported to have antifungal activity (WOLDEMICHAEL and WINK 2001). Saponins 
isolated from Panax notoginseng exhibited an inhibitory effect on Aphanomyces 
coch/ioides zoospore motility (MA, MIZUTANI, MAL TERUD, LU, DUCREY and 
TAHARA 1999). Saponins also show antimicrobial activity (KILLEEN, MADIGAN, 
CONNOLLY, WALSH, CLARK, HYNES, TIMMINS, JAMES, HEADON and POWER 
1998; IORIZZI, LANZOTTI, RANALLI, DEMARINO and ZOLLO 2002). 
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QIU, LI, XIONG, DONG, CHAI, FARNSWORTH, PEZZUTO and FONG 
(2000) isolated the saponin chloromaloside A from Chlorophytum malayense, which 
is highly cytotoxic. In vitro studies showed the steroidal saponin to have cytotoxicity 
against human cancer cell lines. Saponins isolated from Camassia leichtlinii show 
cytotoxic activity against human oral squamous cell carcinoma (HSC-2) cells and 
normal human gingival fibroblasts (KURODA, MIMAKI, HASEGAWA, YOKOSUKA, 
SASHIDA and SAKAGAMI 2001). Saponins isolated from Allium chinense have 
antitumor-promoting activity (BABA, OHMURA, KISHI, OKADA, SHIBATA, PENG, 
YAO, NISHINO and OKUYAMA 2000). In vivo studies on antitumor activity by 
Nigella sativa seed extracts yielded the principle bioactive compound a-hederin, a 
monodesmosidic triterpene saponin (KUMARA and HUAT 2001). TRUTE, GROSS, 
MUTSCHLER and NAHRSTEDT (1996) showed the saponin a-hederin, isolated 
from Hedera helix, to have significant antispasmodic activity. 
Saponins also have antiviral activity. Triterpenoid saponins from the 
Fabaceae showed anti-herpes virus activity (KINJO, YOKOMIZO, HIRAKAWA, SHII, 
NOHARA and UYEDA 2000). Saponins from Tieghemella heckelii yielded antiviral 
activity (GOSSE, GNABRE, BATES, DISUS, NAKKIEW and HUANG 2002). A 
mixture of tea-seed saponins from Camellia sinensis var sinensis, inactivate human 
type A and B influenza viruses. However, these saponins are also toxic to the host 
cells and further studies need to be conducted (HAYASHI, SAGESAKA, SUZUKI 
and SUZUKI 1999). Saponins from soybean exhibit strong anti-HIV activity in vitro 
(NAKASHIMA, OHUBO, HONDA, TAMURA, MATSUDA and YAMAMOTO 1989). 
Korean red ginseng saponins have been shown to have various effects on the 
spatial memory (BURESOVA and BURES 1982; JAENICKE, KIM, AHN and LEE 
1991; PARK, NAM, HYAN, JIN, CHEPURNOV and CHEPUNORA 1994). KIM, 
JANG, SEONG, RHEN, CHO and KANG (1996) demonstrated the effects of Korean 
red ginseng saponins on cocaine-induced intoxication. Korean red ginseng saponins 
were also found to have an effect on ethanol-induced amnesia (LEE, MOON and 
YOU 1999). 
Saponins are present in many bulbous South African plants. When working 
with M. natalensis, especially aqueous extracts, there develops persistent foam, 
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which is characteristic of saponins. HUTCHINGS (1989) suggested that M. 
natalensis contains saponins, however, there is no definite evidence. 
3.1.2. Method of Detection 
3.1 .2.1. Froth Test 
One hundred mg of dried M. natalensis bulb material were placed into a test-
tube containing 10 ml distilled water. The test-tube was sealed with a rubber stopper 
before being vigorously shaken for 30 sec. The test-tube was left to stand vertically 
for 30 min, before being examined. If a froth layer greater than 1 cm existed on top of 
the water surface, then it could be presumed that there are saponins in the plant. 
However, this is just a simple test that does not prove that there are definitely 
saponins in the material. A further test exists, which does prove that there are 
definitely saponins within the bulbs of M. natalensis. This is the haemolysis test 
(LUYT, JAGER and VAN STADEN 1999). 
3.1.2.2. Haemolysis Test 
This test makes use of blood agar plates to which the plant extracts are 
added. The blood agar plates were made up as follows: Columbia blood agar base 
(OXOID) (39 g) was suspended in 1 I distilled water. The agar solution was 
autoclaved at 121°C for 15 min, and then cooled to 50°C in a waterbath. Under 
aseptic conditions, 50-70 ml sterile citrated blood (100 g tri-sodium citrate in 500 ml 
distilled water; 15 ml per 500 ml blood) from either a sheep or cow was added. The 
blood agar was dispensed into sterile Petri dishes. 
Wells were cut into the blood agar equidistant apart. The bottom of each well 
was sealed by using a 1-2 mm diameter glass rod, heated over a flame. Sealing the 
wells prevented the extracts from spreading beneath the blood agar. Using a Pasteur 
pipette, the aqueous plant extract (10 mg/ml) was added. Each well was filled. 
Distilled water and saponin (Sigma) (10 mg/ml) were included as negative and 
positive controls respectively. The plates were allowed to stand at room temperature 
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for one h, after which the wells were examined for zones of haemolytic activity. 
These zones appear as clear rings around each well. 
3.1.3 . Results and Discussion 
After 30 min, there was a very distinct froth layer on the surface of the water 
(Figure 3.1A). This froth layer remained for more than 12 h. Therefore, in order to 
confirm the results of the froth test a haemolysis test was also conducted. Saponins 
are known to have haemolytic activity (WAGNER, BLADT and ZGAINSKI1984) . The 
results of the haemolysis test confirmed the froth test findings as very clear zones of 
haemolysis were observed (Figure 3.1 B). The presence of saponins could explain 
some of the pharmacological activities shown in Section 2. 
3.2. Cardiac Glycosides 
3.2.1. Introduction 
Cardiac glycosides are naturally occurring steroids that have a powerful 
stimulating action on the cardiac muscle. Although new synthetic intropic agents are 
appearing on the market, cardiac glycosides of plant origin still remain the chief 
drugs in treating cardiac insufficiency (BRUNETON 1995). Despite the early lack of 
awareness of their therapeutic potential, some of these drugs were known and used 
for their cardiac toxicity (BRUNETON 1995). These compounds may occur in any of 
the plant's organs, but in most cases, at very low concentrations (BRUNETON 
1995). Their chemical structures are homologous, and comprise of a steroidal 
algycone (two types) and a sugar moiety, which is most often an oligosaccharide. 
The aglycones all have a classic, tetracyclic steroidal nucleus. The four rings (A, B, 
C, and D) normally have a cis-trans-cis configuration . Sometimes the rings are 
bound in a trans-trans-cis configuration, but this is only so in a few cases 
(BRUNETON 1995). The aglycone has two hydroxyl groups and a p substituent (u, 
p-unsaturated lactone). The lactone ring is attached at C-17 and it is the size of the 
lactone ring, which distinguishes the two groups of cardiac glycosides (WAGNER, 
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BLADT and ZGAINSKI 1984; BRUNETON 1995}. Cardenolides are C23 steroids 
containing an a, p-unsaturated y-Iactone ring (butenolide), Bufadienolides are C24 
homologs of cardenolides which contain a di-unsaturated 8-lactone ring 
(pentadienolide). The lactone ring is essential for activity, with the substituted 
lactones remaining biologically active even when the steroid moiety is removed 
(RANG and DALE 1987). 
Western medicines use cardenolides as cardio-active drugs, while 
bufadienolides are seldom used as cardiac drugs because of their low therapeutic 
index and adverse side effects (RANG and DALE 1987). Cardenolides are more 
commonly and abundantly found in plants than bufadeinolides (HEGNAUER 1970). 
Cardiac glycosides are known to act on the heart at different levels. They affect the 
force and speed of contraction, rate and electrophysiological properties of the heart. 
Patients with cardiac insufficiency are treated with cardiac glycoside drugs resulting 
in an increase in the force and speed of contraction, but a decrease in heart rate. 
However, there is a notably small margin between their therapeutic effect and their 
toxicity, which means that dosage of cardiac glycoside drugs must be administered 
with great care. 
Bufadienolides have antiviral activity. KAMANO, SATOH, NAKAYOSH, 
PETTIT and SMITH (1988) reported bufadienolides to have antirhinovirus properties. 
KAMANO, SATOH, NAKAYOSH, PETTIT and SMITH (1988) also reported that 
synthetic bufadienolides, including scillarenin, are active against poliovirus. 
Bufadienolides have also been reported to have antitumor properties. Bufadienolides 
isolated from Kalanchoe pinnata and Kalanchoe daigrenontiana were shown to be 
antitumor-promoting (SUPRATMAN, FUJITA, AKIYAMA, HAYASHI, MURAKAMI, 
SAKAI, KOSHIMIZU and OHIGASHI 2001). It was suggested that the bufadienolides 
are potential cancer chemopreventive agents. 
3.2 .2. Method of Detection 
The method described by JAGER and VAN STADEN (1995) was used to 
screen for cardiac glycosides. One g of dried powder of M. natalensis bulb material 
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was extracted with 30 ml 53% ethanol containing 3% lead acetate under reflux for 15 
min. The extract was allowed to cool before being filtered through Whatman No. 1 
filter paper using a BOchner funnel. The filtered extract was then acidified with acetic 
acid and partitioned th ree times in succession with 15 ml dichloromethane. The 
dichloromethane phases were filtered over sodium sulphate (anhydrous) and 
evaporated to . dryness. The residue was dissolved in 1 ml dichloromethane: 
methanol (1 :1 v/v). The dissolved extract (30-50 1-11) was strip-loaded onto a silica gel 
60 F254 TLC plate (Merck). The plates were run in an ethyl acetate: methanol: water 
(81:11:8 v:v:v) solvent system. Twenty 1-11 proscillaridin A (1 mg/ml) (Sigma) were 
used as a reference compound. The TLC plate was sprayed with antimony III 
chloride (SbCb) reagent (20% SbCI3 in ethanol) to detect bufadienolides. After 
spraying the plate, it was incubated at 100°C for 6 min . Bufadienolides can be 
viewed under visible and UV366 nm light. The same method was used to screen for 
cardenolides, except that Kedde's reagent (WAGNER, BLADT and ZGAINSKI 1984) 
was sprayed over the plates. 
3.2.3. Results and Discussion 
After spraying the TLC plates with antimony trichloride reagent, and 
examining under UV366 nm it was clear that there are bufadienolide-type cardiac 
glycosides present in the bulbs of M. natalensis. This confirms the reports that these 
kinds of glycosides may be present in this species. It is clear that there are more 
than one kind of bufadienolide found in the bulbs, as there are a number of bands on 
the TLC plate. One of the bands matches the reference bufadienolide, proscillaridin 
A (Figure 3.2). 
No cardiac glycoside bands were detected after spraying with Kedde's 
reagent. Kedde's reagent detects the presence of the cardenolide unsaturated 
lactone ring. The lack of bands indicates that there are no cardenolides present in 
the bulbs of M. natalensis. Since the bulbs were shown to contain cardiac 
glycosides, extreme care should be taken in using this species in traditional 
medicines. If administered incorrectly, it could have serious if not fatal 
consequences. 
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Figure 3.1. (A) Pill vial containing dried M. nata/ensis material in distilled water. The 
arrow points to the froth layer that resulted from shaking, indicating the 
possible presence of saponins. (B) Blood agar plate. The arrow points to 
the zones of ruptured erythrocytes (haemolysis test), which confirms the 
presence of saponins within the bulbs of M. nata/ensis. SC = saponin 






Figure 3.2. TLC plate developed 
with ethyl acetate: methanol: water 
(81 :11:8 v:v:v) solvent system. The 
plate was stained with antimony 
trichloride reagent and viewed under 
UV366 nm. MN = M. nata/ensis bulb 
extract. PA = Proscillaridin A 
(reference bufadienolide). Florescent 
bands indicate bufadienolides. Arrow 
indicates bufadienolide from M. 
nata/ensis with same Rf as the 
reference compound. 
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3.3. Alkaloids 
3.3 .1. Introduction 
In plants, alkaloids occur as soluble salts such as citrates, malates, tartrates, 
meconates, isobutyrates and benzoates. They may also occur in combination with 
tannins (BRUNETON 1995). It has been estimated that 15-20% of vascular plants 
contain alkaloids. Although alkaloids are widely distributed in the plant kingdom, 
there are certain groups that are characteristically devoid of them (FARNSWORTH 
1966). Since it is possible to obtain false-positive results when screening for 
alkaloids, it has been suggested that only 9-10% of vascular plant species contain 
alkaloids (FARNSWORTH 1966). False-positive reactions can most often be 
attributed to the presence of proteins found within the plant material. 
In most cases, alkaloids are found in the peripheral tissues of plants, i.e. 
external layers of the bark of stems and roots . They are sometimes found in the 
integument of seeds. Most alkaloids have antimetabolite properties and therefore 
compartmentalized storage is necessary. They are mainly stored in cell vacuoles, 
which are sometimes specialized (Iaticiferous). Although they are stored in the 
vacuoles, alkaloid synthesis most often occurs in other specific sites such as growing 
roots, laticiferous cells or chloroplasts. The alkaloids are then transported to the 
storage sites (BRUNETON 1995). Most of the alkaloids found in plants are 
derivatives of tertiary amines, while others contain primary, secondary or quaternary 
nitrogens (WAGNER, BLADT and ZGAINSKI 1984). The basicity of alkaloids varies 
considerably, depending on which of the four types are being represented 
(WAGNER, BLADT and ZGAINSKI 1984; BRUNETON 1995). 
Alkaloids have a wide range of pharmacological uses. Acetone extracts from 
leaves of Murraya koenigii revealed carbazole alkaloids, which have antimicrobial, 
anti-inflammatory, and antioxidant activity (RAMSEWAK, NAIR, STRASBURG, 
DEWITT and NITISS 1999). These alkaloids also have mosquitocidal properties. 
NAVARRO and DELGADO (1999) reported that alkaloids from Bocconia arborea 
have both antibacterial and antifungal activity. The isolated alkaloids were active 
against both Gram-positive and Gram-negative bacterial strains. The alkaloids were 
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also active against the fungus Candida albicans. Alkaloids have also been reported 
to have anti-inflammatory activity (WHITEHOUSE, FAIRLIE and THONG 1994). 
GUHA, DAWN, DUTTA, CHAKRABORTY and PAIN (1999) reported anti-
inflammatory activity from alkaloid extracts of plants used in homeopathic medicines. 
Extracts were also reported to be extremely potent cardiotoxins. Naturally occurring 
bisbenzylisoquinoline alkaloids were reported to be cytotoxic. Bisbenzylisoquinoline 
alkaloids isolated from nine different plant species showed antiplasmodial activity 
and were cytotoxic to human KB cells (ANGERHOFER, GUINAUDEAU, 
WONGPANICH, PEZZUTO and CORDELL 1999). 
Alkaloids were reported to be present in M. natalensis (= Scilla natalensis) 
(RAFFAUF 1996). However, the same reference reported that S. natalensis did not 
contain alkaoids. The reason for this contradiction may be attributed to the ongoing 
name changing and shuffling of the genus Scilla. As mentioned in Section 1.5 the 
species S. kraussii and S. dracomontana were once placed under the species S. 
natalensis. RAFFAUF (1996) also placed S. natalensis under the family Liliaceae 
instead of the family Hyacinthaceae, which indicates the confusion of the genus. 
3.3.2. Method of Detection 
Alkaloids are not always easily detected and therefore, three extraction 
methods were used to screen for their presence using Dragendorff Reagent. 
3.3.2 .1. Method A 
Two g of dried M. natalensis bulb material were ground in a mortar with 2 ml 
10% ammonia solution for 1-2 min. Seven g basic aluminum oxide were added and 
mixed thoroughly with the plant material. The mixture was packed loosely into a 
glass column (1.5 x 20 cm). Ten ml chloroform were added. The column was eluated 
with an additional 5 ml CHCb and the eluate collected. The eluate was evaporated to 
1 ml and 20 J.JI strip-loaded onto a silica gel plate (Merck). The plates were run in an 
ethyl acetate: methanol: water (100: 13.5: 1 0 v:v:v) solvent system and sprayed with 
Dragendorff reagent (WAGNER, BLADT and ZGAINSKI 1984). The plates were 
examined under visible light for brown or orange-brown zones. 
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3.3.2.2. Method B 
Two g of dried M. natalensis bulb material were mixed thoroughly with 2 ml 
10% ammonia solution before being extracted for 10 min with 10 ml methanol under 
reflux. The extract was filtered under vacuum through Whatman No. 1 filter paper 
and the filtrate collected and concentrated to 1 ml through evaporation. Twenty 1-11 
were strip-loaded onto silica gel plates (Merck) and run in ethyl acetate: methanol: 
water (100: 13.5: 1 0 v:v:v) and toluene: ethyl acetate: diethylamine (70:20: 1 0 v:v:v) 
solvent systems. The plates were sprayed with Dragendorff reagent (WAGNER, 
BLADT and ZGAINSKI 1984) and examined under visible light for brown or orange-
brown zones. 
3.3.2.3. Method C 
Two g of dried M~ natalensis bulb material were extracted under constant 
stirring with 20 ml 96% ethanol for 30 min. The extract was filtered under vacuum 
through Whatman No. 1 filter paper and 15 ml water added. The ethanol was 
removed carefully by evaporation using a hot plate. Five ml 2 N NaOH were added 
to basify the extract. The basic extract was partitioned with 10 ml dichloromethane. 
The organic phase was collected and filtered through Whatman No. 1 filter paper 
before being partitioned against 2 ml 0.1 N Hel. The aqueous phase was divided in 
two and a few drops of Dragendorff and Meyer's reagent (WAGNER, BLADT and 
ZGAINSKI 1987) were added respectively. The extracts were observed for a 
precipitate. 
3.3.3. Results and Discussion 
In all cases no distinct brown or orange-brown zones were noted. Neither 
were any white precipitates observed with the Meyer's reagent. According to 
FARNSWORTH (1966), the presence of alkaloids in plant material can vary 
depending on the age, climate, habitat, plant part tested, season, time of harvest, 
chemical races of plants and the sensitivity of the alkaloid type to the reagents used. 
The plant material used had not been stored for a long period of time and so any 
alkaloids that were present should still be in the material. Therefore it can be 
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Tannins can be placed into two groups on the basis of their phenolic 
constituents. The first group is the hydrolysable tannins or pyrogallol tannins, which 
are yellow-brown amorphous substances. These tannins form colloidal dispersions 
after dissolving in hot water. Tannins are very astringent and have the ability to tan 
hide. They are esters that can be hydrolyzed by boiling with dilute acids and produce 
phenolic compounds that are usually derivatives of gallic acid and a sugar. The 
second group is known as condensed tannins or phlobatannins. These are polymers 
of phenolic compounds that are related to the flavonoids. They are similar in general 
properties to the hydrolysable tannins, however, these tannins are not very soluble in 
water. Insoluble polymers known as phlobaphenes are formed once these tannins 
are treated with boiling dilute acid. 
Tannins like the previously discussed phytochemicals, have been reported to 
have pharmalogical properties. Tannin isolated from the fruits of Punica granatum 
showed antibacterial activity when tested against Staphylococcus aureus 
(MACHADO, LEAL, AMARAL, DOSSANTOS, DASILVA and KUSTER 2002). In an 
evaluation of tea-polyphenols, HASHIMOTO, ONO, MASUOKA, ITO, SAKATA, 
SHIMIZU, NONAKA, NISHIOKA and NOHARA (2003) reported tannins to have an 
antioxidative effect in vitro. WANG, CHEN and YANG (2002) found the tannin 
Cuphiin 0-1 to have antitumor activity. The activity was reported in both in vitro and 
in vivo studies. Tannins have also been shown to have antiviral activity. Casuarinin, 
a tannin isolated from the bark of Terminalia arjuna, was active against Herpes 
simplex virus type-2 (CHENG, LIN and LIN 2002). 
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3.4.2 . Method of Detection 
Tannins were screened for, by using the gelatin-salt block test (WILSON and 
MERRIL 1931). Five hundred mg of dried powdered M. natalensis bulb material were 
extracted for 30 min with 5 ml distilled water, using an ultrasound bath. The extract 
was filtered under vacuum through Whatman No. 1 filter paper before 1-2 drops of 
10% sodium chloride solution was added. This is done to eliminate any non-tannin 
compounds that may give a false-positive result. The extract was refiltered through 
Whatman No.1 filter paper and the filtrate collected . Four drops of the filtrate were 
placed into four wells in a porcelain cavity plate. One drop of 1 % gelatin solution was 
added to one of the wells and observed for a precipitate. One drop of 1 % gelatin 
solution and one drop of 10% sodium chloride were added to another of the extract 
wells and observed for a precipitate. One drop of 10% ferric chloride solution was 
added to a third extract well and observed for colour change. 
3.4.3. Results and Discussion 
The development of a precipitate with the addition of gelatin or gelatin and 
sodium chloride is indicative of the presence of tannins. The basis for the reaction is 
that tannins preCipitate proteins. In this case the protein was gelatin. The addition of 
sodium chloride makes the reaction more sensitive by enhancing the "salting out" of 
the protein-tannin complex. Sodium chloride was used as the control. If a precipitate 
is only observed in the well containing NaCl, then the results would be a false-
positive. Ferric chloride is used to confirm a positive test by inducing a precipitate 
colour change to blue, green or green-blue. This colour change is the result of a 
reaction between ferric chloride and the phenolic functions of the tannins. If the 
extracts contained phenolic or polyphenolic compounds other than tannins, a 
negative gelatin-salt test would be observed, but there would be a colour change 
with the addition of ferric chloride. No precipitate was observed with the addition of 
gelatin or sodium chloride. The addition of ferric chloride did not cause a colour 
change. Although there are no documented indications that there are tannins present 
in the bulbs of M. natalensis, the lack of tannins had never been confirmed. A 
negative result from this screening indicates that there are no or very little tannins in 
the bulbs of M. natalensis. 
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3.5. Summary 
• The bulbs of M. natalensis were screened for the following phytochemicals: 
saponins, cardiac glycosides, alkaloids and tannins. 
• Fresh and dry material were screened for saponins using the froth and 
haemolysis tests. 
• Positive results were obtained for both tests. After shaking the material in 
water, a layer offroth that remained for 12 h, was obseNed. 
• The haemolysis test resulted in clear zones encircling the extracts. These 
zones were as a result of the saponins causing the erythrocytes to rupture. 
• Dry material was screened for both cardenolides and bufadienolides. 
• No unsaturated lactone ring was detected with Kedde's reagent, which 
indicates that there are no cardenolides present within the bulbs of M. 
natalensis. 
• Bufadienolide type cardiac glycosides were detected with antimony trichloride 
stain reagent. One of the TLC bands matched chromatographically the 
reference bufadienolide, proscillaridin A. 
• No alkaloids were detected within the bulbs of M. natalensis using both 
Dragendorff and Meyer's stain reagents. 
• No tannins were precipitated out using the gellatin-salt block test. 
• It can be concluded that saponins and bufadienolides are present in the bulbs 
of M. natalensis. The pharmacological activity shown in Section 2 may be a 
result of these types of phytochemicals. Both alkaloids and tannins were not 




GROWTH ANALYSIS OF MATERIAL COLLECTED 
FROM FIELD TRIALS 
Since the beginning of recorded history, approximately 40 000 plant species that 
are used for ethnomedical purposes have been collected and gathered from the wild 
instead of being grown in cultivated fields (MATHE 1988). In recent times, people have 
become more aware of the need to protect plant genetic resources especially now 
when there is an increase in the destruction of natural ecosystems. The necessity to 
ensure a continued supply of plants and plant products has lead to the introduction of 
wild species into cultivation. In a South African context, the increasing demand for 
medicinal plants has resulted in over-exploitation of many of the wild populations 
(MANDER, MANDER and BREEN 1996). There is a growing need for sustainable use 
of natural resources. However, with the increase in non-specialist gatherers and 
commercial traders, the demand for medicinal plants is already too large to be met by 
sustainable harvesting. VAN STADEN (1999) mentioned that the only real solution 
would be to develop medicinal plants as crops through small-scale farming. Cultivation 
of medicinal plants would not only lead to the sustainable development and protection 
of natural resources, but also to assist in generating employment through small 
entrepreneurs. The successful domestication of wild medicinal plant species suggests 
that there would be an improvement in the quality of the raw, crude plant extracts. This 
would enable the standardization of the content of the active ingredients and 
homogeneous plant populations necessary for modern production, processing and 
utilization (MATHE 1988). 
The introduction of medicinal plants into cultivation is not something new. Many 
species have been cultivated by different ancient civilizations. As early as the 16th 
century, medicinal plants have been cultivated as cash crops. However, the movement 
of medicinal plants from natural habitats to cultivated fields is not as simple as 
transplanting the plants into a new location. According to BERNATH (1986) medicinal 
plants have coevolved with their natural ecosystems. Any changes in the growth 
environments of the plant, such as those associated with transplanting from a wild 
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ecosystem to a cultivated field, can result in modifications in plant growth, development, 
and natural product content. MATHE (1988) stated that the problems of introduction are 
similar whether the material being transplanted is from cultivation or from a wild 
population. Transplanted plants must acclimatize to the new environment, which is 
associated with a new set of abiotic and biotic ecological factors that may exert 
significant selection pressures that are different from those of the native habitat. 
The domestication of wild species requires the manipulation of the field ecology 
to match the environmental requirements that are necessary for the plants to grow and 
reproduce. In terms of medicinal plants, the ecological goal would be to eliminate the 
differences between the wild and cultivated habitats to prevent any detrimental affect on 
the production of economically important natural products (MATHE 1988). Most 
assumptions suggest that the introduction of a plant to a new habitat would have a 
detrimental affect on the economic production of the species by decreasing growth and 
the chemical yield, however MATHE (1988) suggests that this can be prevented. It is 
often possible to adjust the planting time, soil conditions and several other aspects of 
cultivation to mimic the natural system. Various species are adapted to specific 
phytogeographical systems and any attempt in trying to introduce them into different 
climatic regions would fail. Factors such as the time of frost, water availability, day 
length, and growing season temperatures can determine the suitability of a new location 
for specific species. 
Although the cultivation of medicinal plants has been suggested before, there 
remains a lack of understanding with respect to the cultivation and the economics of 
producing medicinal plants by small-scale farmers. MANDER, MANDER and BREEN 
(1996) suggested that it is this lack of understanding that is one of the most limiting 
factors in the commercialization of indigenous medicinal plants. JAGER and VAN 
STADEN (2000) mentioned the need for basic information on how to grow the plants, 
planting to harvest periods, yield, expected financial return, storage and shelf-life are 
needed before small-scale farmers can be expected to venture into cultivating medicinal 
plants. It is essential that field trials be conducted in order to establish this information. 
One of the problems with CUltivation of medicinal plants is obtaining material to cultivate. 
There are problems associated with the availability of seed stocks and the harvesting of 
seed from the wild (JAGER and VAN STADEN 2000). Vegetative propagation is one 
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possible solution (MANDER, MANDER, CROUCH, McKEAN and NICHOLS 1995), 
while micropropagation is another. Micropropagation protocols have been established 
for many South African medicinal plant species including the Scilla species 
(APPLETON and VAN STADEN 1995; McCARTAN and VAN STADEN 1998; RABE 
and VAN STADEN 1999; ZSCHOCKE and VAN STADEN 2000). As mentioned by 
JAGER and VAN STADEN (2000), sophisticated facilities are not required for 
hardening off microplants. It is possible then for small-scale farmers to take plants 
directly from tissue culture and acclimatize them themselves. This would reduce the 
price of the stock material making it more feasible for the farmers. 
4.2. Methodology 
4.2.1. Cultivation Sites 
Two sites in South Africa were selected to cultivate M. natalensis bulbs as a 
crop on a small-scale basis. The two sites selected were the smallholding H2A 
Botanicals and the premises at the University of Fort Hare (Figure 4.1). 
4.2.1.1. H2A Botanicals 
H2A Botanicals is a private farm specializing in growing cash crop vegetables. 
The farm is situated near Hillcrest in the province of KwaZulu-Natal, South Africa. 
The geography of the region is "hilly" terrain with steep valleys (Figure 4.2C). It is 
positioned approximately 29° 47' Sand 30° 50' E at an altitude of 488 m above sea 
level. It is situated in the "rain belt" and has a high occurrence of mist. The mean 
annual rainfall for the area is over 1000 mm. Temperatures range from 18-26°C in 
summer to 9-21°C during winter. 
The plants used were taken directly from tissue culture to be hardened off in 
seedling trays under 80% shadecloth (Figure 4.2A). The soil mixture used in the 
hardening off process was 33% Umgeni River sand and 66% Gromor® (National 
Plant Food) Seedling Mix. After three weeks the seedlings were placed under 30% 
shadecloth. Once the seedlings had grown large enough, they were removed from 
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Northern Cape 
Alice - Fort Hare 
Hillcrest - H2A 
Botanicals 
D Distribution of M. natalensis 
Provincial map of South Africa showing the distribution of wild 
populations of M. nataiensis and the two cUltivation sites, H2A Botanicals 
and the University of Fort Hare where field trials were conducted. 
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Figure 4.2. (A) M. nata/ensis bulblets being acclimatized in seedling trays under 80% 
shadecloth at H2A Botanicals. (B) Young plants were put into bags after 
acclimatized to allow the plants to establish and grow before planting out 
into the field. (C) Overview of the terraced site at H2A Botanicals where 
plants were planted out. (0) Rows of M. nata/ensis plants growing in the 
irrigation and fertilizer plot. (E) Bulbs harvested after two years of growing 
in the field. 
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Organic fertilizer, R.U.M. (Pvt) Ltd., was applied as a soil drench. The bagged 
young plants were placed under 20% shadecloth until planting out into the fields. 
Field trial planting was done in September 2000. 
4.2.1.2. Fort Hare 
The University of Fort Hare is situated outside the town of Alice in the Eastern 
Cape, South Africa. Positioned 32° 47' Sand 26° 51' E, at an altitude of 520 m above 
sea level, it is outside of the "eastern coast rain belt". The mean annual precipitation 
for the area is 612 mm. Temperatures range from 16-28°C in the summer months to 
6-200 C during the winter months. 
The young M. nata/ensis plantlets were hardened off from tissue culture at the 
University of Natal, Pietermaritzburg. The seedlings were hardened off in seedling 
trays in a mist house under high humidity. Fully hardened off plants were sent to Fort 
Hare to be planted out in the fields. Field trial planting out was done in mid-October 
1999. 
4.2.2. Cultivation Methods 
Cultivation was carried out on three plots. The first plot was the control 
treatment, which received no fertilizer additives or supplementary irrigation. The 
plants were grown in tilled topsoil and relied on rain for their water source. The 
second plot was fertilized only and was not irrigated (referred to as the fertilizer 
treatment). The fertilizer used at the H2A Botanicals site was a mixture of composted 
horse and chicken manure at a ratio of 2:1. The fertilizer used at the Fort Hare was 
inorganic fertilizer NPK 232(22) (Nitrochem). The third plot was irrigated and fertilized 
(referred to as the irrigation treatment). The plants were planted approximately 30 cm 
apart in rows with 50 cm spacing between rows. 
4.2.3. Harvesting 
Twenty bulbs were removed from the initial planting out batches, weighed and 
dried to form the initial samples. After six months of growing in the field 20 plants 
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from each of the three treatments were harvested and fresh weights of the bulbs 
recorded. Due to harvesting being done during summer and then again after winter, 
the total fresh weights of the plants were not used for growth analysis as leaf 
senescence affects the results. Instead bulb weight was analysed as the growth 
variable. Harvesting was then done on a six-monthly basis for a period of two years. 
Average dry weights and standard errors of the bulbs were calculated and compared 
using Fisher's pairwise comparisons at 5% level of significance. 
4.2.4. Drying and Storage 
The harvested bulbs were dried in ovens at 50°C for 72 h, after which dry 
weights were recorded . Bulbs were grouped into fives to form four sample groups. 
The five bulbs were ground together and stored in honey jars in the dark at 24°C. 
This was done for each of the treatments for each harvest from both H2A Botanicals 
and Fort Hare. 
4.3. Results and Discussion 
4.3.1 . H2A Botanicals 
The young M. natalensis plantlets were found to harden-off very successfully 
using very basic and economical methods. With the use of different shadecloth 
densities, the plantlets can be hardened off directly from tissue culture with 83% 
survival. This is important in terms of providing stock plants for small-scale farmers. 
Plants can be obtained directly from tissue culture and hardened off by the farmers 
themselves at low cost. This would also reduce the cost of the stock plantlets as the 
tissue culture supplier would not have to harden the plants off before selling them. 
One of the problems that were noticed with many of the plants growing in the 
field plots was chlorosis of the leaves. Many of the leaves showed signs of leaf 
yellowing. The cause of the chlorosis was linked to a combination of chicken manure 
and excessive watering. The addition of chicken manure resulted in a change in soil 
pH from 5 to almost 8. During the summer months, excessive rainfall and poor run-off 
or drainage resulted in water logging. M. natalensis are found mainly in slightly acidic 
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soils that are usually well drained. Once the chicken manure was broken down and 
leached from the system and the pH returned to around 5, the chlorosis disappeared 
and the plants had a more healthy appearance. The leaves of M. natalensis are known 
to be infected by the badnavirus (GEORGE, BANDU and VAN STADEN 1999), which 
is a retrovirus that infects many horticultural crops. However, this virus was not 
observed on the leaves of any of the harvested material. 
The average dry weight of the bulbs increased exponentially once planted out 
for cultivation. Results from the control plot indicated that the relative growth rate 
(RGR) increased sharply over the period of acclimatization and establishment to six 
months (March 2001) of growing in the field (Figure 4.3). The RGR decreased 
sharply over the next six months (March 2001 -September 2001). This decrease 
occurred during the months April to August, which are the winter months in the 
southern Hemisphere during which the eastern half of South Africa experiences very 
low rainfall. Like most monocotyledons, especially bulbous species, M. natalensis 
follows a seasonal growth pattern. During the dry winter months the leaves senesce, 
and the bulbs resprouts in the following spring as seen in the picture taken of the 
bulbs in September 2001 (Figure 4.3). The bulbs remain in a state of dormancy, 
using what nutrients and water it has in reserve to maintain the basic physiological 
systems needed to survive the winter months. During these months very little growth 
occurs which is evidenced by the average dry weights (Figure 4.3). No significant 
differences (p:50.05) were found between average dry weights of the harvests March 
2001 and September 2001, for plants growing in the field for six and 12 months 
respectively. No significant differences (p:50.05) were found between average dry 
weights of the 18 month (March 2002) and 24 month (September 2002) harvests. 
Growth did increase over the summer season between September 2001 and March 
2002. However, the RGR although increasing, was not as pronounced as during the 
first growing season. 
Bulbs that had been growing in the field and received no irrigation or fertilizer 
other than from natural sources reached almost marketable size (±300 g fresh 
weight) after only two years in the field. After 24 months cultivation, the average dry 
weight of bulbs grown under these conditions was 38.4 g (Figure 4.3). The average 
dry weight of the bulbs grown in the fertilizer treatment (Figure 4.4) and the irrigation 
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treatment (Figure 4.5) were not significantly different (p:50.05) from the control 
treatment (Figure 4.3). The average dry weights of the bulbs growing in fertilizer 
treatment and irrigation treatment after 24 months were 36.5 g and 37.2 g 
respectively, which were lower than the average dry weight of the bulbs from the 
control treatment. The plants grown with fertilizer had similar growth trends (Figure 
4.4) as those from the control treatment. It is very clear then that there were no 
relationships between fertilizer and bulb weight. Whether fertilizer is added to the soil 
or not did not seem to have an affect on the size of the bulbs or the rate of growth. 
However, the bulbs harvested from the irrigation treatment after 12 months 
(September 2001) were significantly different (p:50.05) from those harvested in March 
of the same year (Figure 4.5). The difference in average dry weight shows that the 
bulbs actually increased in weight over the winter months. Bulbs harvested from the 
irrigation treatment still had leaves as seen in the photograph of the September 2001 
harvest (Figure 4.5). The irrigation treatment was irrigated during the winter months 
between March 2001 and September 2001 , which seems to have caused the plants 
to readjusted their annual rhythm. This adjustment resulted in the plant leaves not 
senescing and the plants continuing to grow as they would do during summer. 
However, this adjustment only occurred in the first year in the field . The second year 
the leaves senesced at the start of winter and the average dry weight of the bulbs 
showed no significant difference (p:50.05) before and after winter. 
Analysis of the effect that the time of harvest had on growth was highly 
significant (p<0.001). This would be expected as growth is relative to time. The type 
of treatment had no significant effect on the dry weight of the bulbs (p=0.249) 
although it was shown that irrigation can effect growth while bulbs are still young. The 
interaction between the treatment and the time of harvest was not significant 
(p=0.140). 
One of the noticeable differences between treatments was the number of 
plants that flowered. After 24 months of growing in the field , 10% of the plants 
harvested from the control treatment were flowering . Only 15% of the plants 
harvested from the fertilizer treatment were flowering while 45% of the plants 
harvested from the irrigation treatment were flowering . It seems that the continued 
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Figure 4.3. Average dry weight and relative growth rate of M. natalensis bulbs 
harvested from the control treatment at the H2A Botanicals site. 
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Figure 4.4. Average dry weight and relative growth rate of M. natalensis bulbs 
harvested from fertilizer treatment at the H2A Botanicals site. 
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Figure 4.5. Average dry weight and relative growth rate of M. natalensis bulbs 
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the crop to flower before the bulbs are harvested. MATHE (1988) suggested that 
morphological traits are frequently modified in the course of introduction to field 
cultivation. However, several species that have been transplanted from the wild to 
cultivated environments have not had any morphological modifications. No noticeable 
morphological changes were found when cultivated M. natalensis plants were 
compared to plants growing under natural conditions. The only difference that was 
noticed between the cultivated plants and plants growing under natural conditions 
was in the length of the flowering stalks. In the natural ecosystem, these stalks grow 
to around 1 m in length. Plants flowering in the cultivated fields produced flowers on 
stalks of between 30-40 cm in length. It is not known whether this is due to a genetic 
trait that was passed on from the ex-plant during tissue culture, or whether it was the 
result of cultivation. 
4.3.2. Fort Hare 
The plants planted at Fort Hare were acclimatized under controlled conditions 
within mist houses. This method of acclimatization resulted in minimal loses, 
however, it is more costly than the method used at H2A Botanicals and therefore if 
the plants were to be sold after acclimatization, the price per unit would be much 
higher than if the plants were sold directly from tissue culture. The only difference 
was that the plants that were obtained at Fort Hare were older and better established 
and so the plants that were planted out into the field were slightly larger than the 
plants that were planted out at H2A Botanicals. 
The bulb weights from the 24 month (November 2001) harvest were not 
available to be included in the analysis. Therefore, growth was only analysed up to 
18 months (April · 2001). The plant material from the 24 month harvest was 
fingerprinted and screened for pharmacological activity. 
The average dry weights of bulbs grown under the control treatment 
(Figure 4.6A), showed similar growth patterns to the bulbs grown under the control 
treatment from the H2A Botanicals site. Growth increased exponentially over the 
summer months, with no significant difference (pSO.OS) in average dry weight of the 
bulbs over the winter months. The average dry weights of the bulbs harvested from 
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the fertilizer treatment (Figure 4.6B) also showed similar growth patterns to those 
from the H2A Botanicals site. The average dry weight of bulbs harvested in 
November 2000 from the irrigation treatment (Figure 4.6C), were significantly higher 
(p:50.05) than the average dry weight of bulbs harvested in November 2000 from both 
control and fertilizer treatments. These findings suggest that it may be possible to 
cause a plant to override its natural annual rhythms while still young, but as the plant 
gets older these rhythms are not easily manipulated. This difference was also 
noticeable at the H2A Botanicals plot. Relative growth rates all showed similar 
patterns to those plants cultivated at H2A Botanicals, except for the irrigation 
treatment where RGR remained constant at Fort Hare between November 2000 and 
April 2001. H2A Botanicals showed a decrease in RGR during the second growing 
season. 
After 18 months of growing in the field, the average dry weights of bulbs grown 
under the control treatment were 52.2 g. The average dry weight of bulbs grown 
under the fertilizer treatment were 56.7 g, while those growing under the irrigation 
treatment were on average larger than both the other plots (60.2 g). Since the bulbs 
that were sent to Fort Hare to be planted out were much larger and already 
established plants, the average dry weights were higher than those from H2A 
Botanicals. Plants from Fort Hare were of marketable size (±300 g fresh weight) after 
18 months in the field. 
Analysis of the effect that the time of harvest had on growth was highly 
significant (p<0.001). This would be expected as growth is relative to time. The type 
of treatment had no significant effect on dry weight of the bulbs (p=0.110). The 
interaction between the treatments and the time of harvest was not significant 
(p=0.230). These findings suggest that if this species is to be grown as a crop for 
commercial sale by farmers, the cost of cultivation would be very low as the plants 
seem to be very hardy and requires little irrigation or fertilizer supplements. This 
would be the ideal type of crop for rural farmers or small-scale farmers that do not 
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Figure 4.6. Average dry weights and relative growth rates of harvested M. natalensis 
bulbs from Fort Hare field trials. Measurements were taken from bulbs 
harvested from (A) Control treatment, (8) Fertilizer treatment, and (C) 
Irrigation treatment. 
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4.4. Summary 
• Tissue cultured M. natalensis plantlets were hardened of by means of simple 
and cost effective methods and successfully grown in cultivation . 
• Plants were grown successfully at two different geographical regions with 
different climatic conditions. 
• Bulbs grew exponentially during the summer growing seasons, reaching 
almost marketable size after 24 months if taken directly from tissue culture and 
hardened off and then planted out into the field . 
• Bulb growth is not dependent on additional fertilizer (organic or inorganic) or 
irrigation as there were no significant differences (p~O.05) in the average dry 
weight of the bulbs grown in the three treatments. 
• Irrigation had an effect on growth of young plants, preventing senescence and 
causing the plants to grow during the dormancy period. 
• Introduction into cultivated ecosystems did not result in any morphological 
modifications. 
• Bulbs started flowering after two years of growing in cultivated fields. Bulbs 
seem to flower more when irrigated. However, there were noticeable 
differences in flowering stalk length when compared to plants growing in 
natural ecosystems. 
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5.1. Introduction 
Thin-layer chromatography (TLC) is a rapid method of drug analysis that can 
be used to efficiently demonstrate the characteristic constituents of a drug or raw 
plant extract. TLC can be used to assess the quality of a drug by providing semi-
quantitative information of the active constituents (WAGNER, BLADT and ZGAINSKI 
1984). TLC also enables the quantitative and qualitative detection of known natural 
products or compounds, and the associated metabolites or breakdown products 
(GIBBONS and GRAY 1998). This has resulted in the development of secondary 
metabolite fingerprinting which allows for the classification of metabolites within the 
same range, and highlights those that are different in profile (VAN MIDDLESWORTH 
and CANNELL 1998). The use of photographic plates can be used to develop 
catalogue spectra of different phytochemicals. The use of stain reagents can facilitate 
secondary metabolite identification. Generally stains are used that give striking 
colours (WAGNER and BLADT 1996). 
Reproducibility is very important when fingerprinting a plant extract. This can 
only be guaranteed if standardized absorption layers are used. Silica gel is generally 
regarded as an efficient absorbent for most TLC separations of most drug extracts. 
Silica gel 60 F254 precoated TLC plates (MERCK) are used in most cases. 
Compounds that have been separated on TLC can be detected by viewing the TLC 
plate under UV light. The advantage of UV detection is that it is non-destructive and 
compounds can be detected at any stage in the separation process (GIBBONS and 
GRAY 1998). However, a major disadvantage of UV detection is that not all 
compounds absorb UV light at wavelengths of 254 or 366 nm. These compounds are 
therefore not visible under UV. Such compounds need to be stained with spray 
reagents to facilitate visualization (GIBBONS and GRAY 1998). Although easy to 
apply, spray reagents are not always specific in that they seldom detect only the 
compounds of a specific class, and often do not react with every compound of the 
class (VAN MIDDLESWORTH and CANNELL 1998). 
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Another problem encountered with TLC fingerprinting is over-loading of 
extracts. By restricting the quantity of material applied to the plates, sharp zones 
(bands) can be obtained. However, it is sometimes necessary to apply larger sample 
volumes if the compounds are present in low concentrations. This can lead to the 
broadening and overlapping of compounds. Compounds are located on the TLC 
plates through the calculation of Rf values. Rf values represent the ratio of the 
distance traveled by the compounds (bands) to the distance traveled by the solvent 
front. These Rf values should be consistent for different TLC separations run under 
standard conditions. 
According to BERNATH (1986) ecological factors have a decisive impact on 
the chemical composition of the plant. Therefore, the variability in natural product 
content and composition are functions of both growth and development, and plays a 
role in determining the optimal harvest time of certain species. PRANCE (1994) 
suggested that the chemistry within individual plant species vary according to the 
ecology, the soil and the climate. YANIV and PALEVITCH (1982) stated that 
depending on the species, the quantity of secondary metabolites increase, decrease 
or remain constant when under water stress. Variations in natural product content 
and composition has been investigated for numerous species. Seasonal variation of 
alkaloids in Crinum moorei was observed by ELGORASHI, DREWES and VAN 
STADEN (2002). No clear trend in seasonal variation was noted with alkaloid yields 
varying from organ-to-organ as well as from season-to-season. DONG, CUI, SONG, 
ZHUO, JI, LO and TSIM (2003) showed that the active constituents of Panax 
notoginseng, including saponins, varied when the plants were grown in different 
geographical regions. The levels of compounds also varied seasonally. 
Essential oil yield in Tagetes minuta varies during the plants growth, with 
young plants having higher contents of certain oils than older plants (CHALCHAT, 
GARRY and MUHAYIMANA 1995). CHALCHAT, GARRY and MUHAYIMANA (1995) 
also found that the nature of the soil, the climate and how the plants were grown had 
little influence on the chemical composition of the oils. Comparative analysis of the 
essential oils of Acanthospermum hispidum showed there to be only slight variations 
over the different seasons (MENUT, MOLANGUI and LAMATY 1995). LOPES, 
KATO, de AGUIAR ANDRADE, MAlA and YOSHIDA (1997) found that the essential 
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oils from leaves of Virola surinamensis showed circadian variation in elemicin and in 
monoterpenes during the rainy season. SOUTHWELL and BOURKE (2001) showed 
that the hypericin content of Hypericum perforatum varied seasonally. The 
concentration of hypericin decreases from 3000 mgtl in summer to 100 mgtl in winter. 
A quantitative investigation by BINNS, LIVESEY, ARNASON and BAUM (2002) on 
Echinacea a widely cultivated taxa that is traded for both medicinal and horticultural 
purposes, showed variations in phytochemistry between wild and cultivated 
populations. Plant age and the type of growth conditions had an effect on 
phytochemical composition and content. 
5.2. Methodology 
5.2.1. Extract Preparations 
Aqueous, methanol and dichloromethane extracts were made of each of the 
four samples for each treatment of each harvest. Two grams of dried material was 
extracted with 20 ml extraction solvent. The material was left to extract for 24 h under 
constant agitation with a magnetic stirrer. The extracts were filtered under vacuum 
through Whatman No. 1 filter paper discs using a BOchner funnel. The filtered 
extracts were taken to dryness and stored in sealed pill vials in the dark at 5°C. 
5.2.2. Sample Preparation 
The extracts residues were dissolved to a concentration of 10 mg/ml with the 
relevant extraction solvents. 
5.2 .3. TLC Separation 
Extracts were applied in 5 ~tI aliquots as 10 mm bands (5 mm spacing 
between extracts). Ten mm margins were left on either side and the origin was 
situated 15 mm from the base. One sample from each treatment was strip-loaded 
onto the TLC plates. Samples were grouped according to the time of harvest. All TLC 
separations were performed at room temperature (±240 C). 
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5.2.3.1. Methariol Extracts 
Methanol extracts were applied to (20x20) Silica gel 60 F254 TLC plates 
(MERCK). The chloroform: glacial acetic acid: methanol: water (64:32:12:8 v:v:v:v) 
system described in Section 3.2 gave the best separation with methanol extracts and 
was subsequently used for preparation of methanol extract TLC fingerprints. Plates 
were developed over 170 mm in the solvent system. These plates were allowed to 
dry before being stained with anisaldehyde-sulphuric acid reagent (0.5 ml 
anisaldehyde, 10 ml sulphuric acid, 85 ml methanol and 5 ml concentrated sulphuric 
acid mixed in this order) and antimony trichloride reagent (20% antimony trichloride in 
chloroform). The stain reagents were sprayed over the plates, which were then 
heated at 110°C for 8 min. The anisaldehyde-sulphuric acid stained plate was 
observed and photographed under visible light. The antimony trichloride stained plate 
was observed and photographed under both visible light and ultra violet (UV) light 
(366 nm). 
5.2.3.2. Dichloromethane Extracts 
Dichloromethane extracts were applied to (20x20) Silica gel 60 F254 TLC 
plates (MERCK). Plates were developed with a dichloromethane: chloroform: 
methanol (10: 1: 1 v:v:v) solvent system. The plates were allowed to dry before being 
stained with antimony trichloride reagent (20% antimony trichloride in chloroform). 
The stained plates were heated at 110°C for 8 min and then observed and 
photographed under UV light (366 nm). 
5.2.3.3. Water Extracts 
Water extracts were applied to (20x20) precoated RP-18 F254 5 TLC plates 
(MERCK). Plates were developed with a dichloromethane: methanol: water (1 :3: 1 
v:v:v) solvent system. The plates were allowed to dry before being observed under 
UV light (366 nm). Plates were stained with anisaldehyde-sulphuric acid reagent (0.5 
ml anisaldehyde, 10 ml sulphuric acid, 85 ml methanol and 5 ml concentrated 
sulphuric acid mixed in this order). The stained plates were heated at 110°C for 8 min 
before being examined and photographed under visible light. 
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5.3. Results and Discussion 
5.3.1. Methanol Extracts 
TLC fingerprints of the methanol extracts are seen in Figures 5.1 for H2A 
Botanicals and Figure 5.2 for Fort Hare. Results of the methanol bulb extracts from 
the H2A Botanicals site show few differences in the chemical compositions between 
mature (M) M. natalensis bulbs and the cultivated plants (Figure 5.1). The only 
noticeable differences in chemical composition occur between Rf 0.4 and Rf 0.5. 
Methanol extracts of bulbs harvested after 12 months (C 12, F12 and 1F12) and 24 
months (C24, F24 and IF24) contained compounds that were also visible in the mature 
plants (Figure 5.1A). 
Results of the methanol bulb extracts from the Fort Hare site showed many 
more differences in chemical composition between the mature bulbs and the 
cultivated plants (Figure 5.2). Noticeable differences were also seen between 
harvests. The 12 month (C12, F12 and IF12) and 24 month (C24 , F24 and IF24) harvests 
were found to be very similar in chemical composition. The 6 month (Cs, Fs and IFs) 
and 18 month (C18, F18 and IF18) harvests were also very similar chemically. A pink 
compound was observed at Rf 0.4 when stained with anisaldehyde-sulphulric acid 
(Figure 5.2A). The 12 and 24 month harvests had a greenish compound at Rf 0.4 that 
matched the mature plant extract. Staining the plates with antimony trichloride also 
produced differences in the chemical composition between Rf 0.25 and Rf 0.5. Again 
the 6 and 18 month harvests differed in chemical profile from the 12 and 24 month 
harvests (Figure 5.2B). Another noticeable difference was observed between Rf 0.8 
and Rf 0.9. A compound, also observed in the bulbs harvested from the H2A 
Botanicals site when stained with antimony trichloride were observed in the 12 and 
24 month harvests only (Figure 5.2B and C). 
Results from both sites suggest that possible the chemical composition of the 
plants differ according to the time of harvest. Plants harvested during the rainy 
season differed chemically from the plants harvested going into the dry season. 
These differences seem to be more pronounced at Fort Hare, which has half the 
mean annual rainfall that H2A Botanicals site. 
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Figure 5.1. TLC Fingerprinting profiles of methanol extracts of M. nata/ensis bulbs 
harvested from the H2A Botanicals site. TLC plates were developed in 
chloroform: glacial acetic acid: methanol: water (64:32:12:8 v:v:v:v) 
solvent system. (A) Anisaldehyde-sulphuric acid stained TLC plate viewed 
under visible light. (B) Antimony trichloride stained TLC plate viewed 
under visible light. (C) Antimony trichloride stained TLC plate viewed 
under UV366 nm. M = mature M. nata/ensis plant, C = control treatment, F = 
fertilizer treatment, IF = irrigation treatment and 6-24 = month of harvest. 
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Figure 5.2. TLC Fingerprinting profiles of methanol extracts of M. natalensis bulbs 
harvested from the Fort Hare site. TLC plates were developed in 
chloroform: glacial acetic acid: methanol: water (64:32:12:8 v:v:v:v) 
solvent system. (A) Anisaldehyde-sulphuric acid stained TLC plate viewed 
under visible light. (8) Antimony trichloride stained TLC plate viewed 
under visible light. (C) Antimony trichloride stained TLC plate viewed 
under UV366 nm. M = mature M. natalensis plant, C = control treatment, F = 
fertilizer treatment, IF = irrigation treatment and 6-24 = month of harvest. 
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There were noticeable differences in the concentrations of the chemicals between the 
extracts of bulbs from the different cultivation treatments and the different harvests. 
Concentration differences are indicated by the intensity of the bands of the same 
compounds. However, no differences in chemical composition were observed 
between bulbs cultivated in the different plots. This indicates that it may not 
necessarily be irrigation that had an effect on the chemical composition but rather 
other factors e.g. temperature, or a combination of factors. 
5.3.2. Dichloromethane Extracts 
The TLC fingerprinting profiles of the dichloromethane extracts of bulbs 
harvested from both the H2A Botanicals and the Fort Hare sites are seen in Figure 
5.3. No visual differences in chemical compositions were observed between the 
cultivated bulbs and the mature M. natalensis bulbs. No differences were noticeable 
between bulbs harvested from the different treatment plots or at different harvests. 
No differences in the chemical constituents were observed between bulbs cultivated 
at the two sites. The only differences that were found were in the concentration of 
some of the compounds. Bulbs harvested after 24 months from the fertilizer only plot 
at the Fort Hare site showed some chemical differences from the other bulbs (Figure 
5.3B). 
5.3 .3. Water Extracts 
The TLC fingerprinting profiles of the water extracts of bulbs harvested from 
both the H2A Botanicals and the Fort Hare sites are presented in Figure 5.4. No 
differences in chemical composition were observed between the water extracts of the 
bulbs harvested from the H2A Botanicals site and the mature bulbs. There were slight 
differences in the concentration of certain compounds (Figure 5.4A). 
The water extracts of bulbs harvested at the Fort Hare site showed differences 
in chemical composition with each harvest (Figure 5.4B). These differences were 
observed between Rf 0.6 and 0.8. The TLC fingerprinting profiles of the 24 month 
harvest was similar to that of mature reference bulbs. 
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Figure 5.3. TLC Fingerprinting profiles of dichloromethane extracts of M. natalensis 
bulbs harvested from the (A) H2A Botanicals site and (B) Fort Hare site. 
TLC plates were developed in dichloromethane: chloroform: methanol 
(10:1:1 v:v:v) solvent system. TLC plates stained with antimony trichloride 
reagent and viewed under UV366 nm. M = mature M. natalensis plant, C = 
control treatment, F = fertilizer treatment, IF = irrigation treatment and 6-24 
= month of harvest. 
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Figure 5.4. TLC Fingerprinting profiles of water extracts of M. natalensis bulbs 
harvested from the (A) H2A Botanicals site and (B) Fort Hare site. TLC 
plates were developed in dichloromethane: methanol: water (1 :3:1 v:v:v) 
solvent system. TLC plates stained with anisaldehyde-sulphuric acid 
reagent and viewed under visible light. M = mature M. natalensis plant, C = 
control treatment, F = fertilizer treatment, IF = irrigation treatment and 6-24 = month of harvest. 
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5.4. Summary 
• TLC fingerprinting profiles were made of methanol, dichloromethane and water 
extracts of M. natalensis. 
• Solvent systems were developed for each extract to allow for comparisons to 
be made between wild mature plants and cultivated plants. 
• Methanol extracts were developed with chloroform: glacial acetic acid : 
methanol: water (64:32: 12:8 v:v:v:v) solvent system and stained with 
anisaldehyde-sulphuric acid and antimony trichloride reagents . TLC plates 
were viewed under UV light (366 nm) and visible light. 
• Differences were found between methanol extract profiles of bulbs for each 
harvest from both cultivation sites. Differences were more noticeable in bulbs 
harvested from the Fort Hare site. 
• Dichloromethane extracts were developed with dichloromethane: chloroform: 
methanol (10: 1: 1 v:v:v) solvent system and stained with antimony trichloride 
reagent. TLC plates were viewed under UV light (366 nm). 
• No differences were found between dichloromethane extract profiles of bulbs 
harvested from both cultivation sites. TLC profiles were the same as the 
mature M. natalensis reference plant. 
• Water extracts were developed with dichloromethane: methanol: water (1:3:1 
v:v:v) solvent system and stained with anisaldehyde-sulphuric acid reagent. 
TLC plates were viewed under visible light. 
• No differences in chemical composition between the water extract profiles of 
bulbs harvested from the HzA Botanicals site and the mature reference plants 
were observed 
• Differences were found between water extract profiles of bulbs harvested from 
the Fort Hare site and the mature reference plant. Bulbs from the 24 month 




PHARMACOLOGICAL ANALYSIS OF MATERIAL 
COLLECTED FROM FIELD TRIALS 
Very little research has been done on seasonal variation in pharmacological 
activity or the effect that plant growth (age) has on the pharmacological activity of M. 
natalensis. In a study by LIGHT, McGAW, RABE, SPARG, TAYLOR, ERASMUS and 
VAN STADEN (2002) the effect of senescence in Siphonochilus aethiopicus on its 
pharmacological activity was investigated. TAYLOR and VAN STADEN (2001) 
investigated the effect of age, season and growth conditions on the anti-inflammatory 
activity of Eucomis autumnalis plant extracts. Significant differences in activity were 
found between plants harvested before and after the growing season. The effect of 
cold storage on the anti-inflammatory activity of E. autumnalis autumnalis also 
showed differences in activity (TAYLOR and VAN STADEN 2002). 
6.2. Extract Preparations 
The dried harvested bulbs (20 in each case) were divided into groups of fives, 
to form four sample groups for each harvest. The five bulbs were ground together 
and stored in honey jars in the dark at ±24°C (room temperature). This was done for 
each of the treatments from both Fort Hare and H2A Botanicals growing sites, at each 
harvest time. 
Aqueous, methanol and dichloromethane extracts were prepared for of each 
of the four samples for each treatment of each harvest. Two g of dried material were 
extracted with 20 ml extraction solvent. The material was allowed to extract for 24 h 
with constant agitation. The extracts were filtered under vacuum through Whatman 
No. 1 filter paper discs using a BOchner funnel. The filtered extracts were taken to 
dryness and stored in sealed pill vials in the dark at 5°C. 
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6.3. Antibacterial Analysis of Cultivated Bulbs 
6.3 .1. Methodology 
6.3 .1.1. Extracts 
Antibacterial screening of extracts from mature M. natalensis bulbs (Section 
2.2) showed that the methanol extracts had the highest antibacterial activity. 
Methanol extracts from the harvested bulbs were therefore routinely screened for 
antibacterial activity. Extracts were dissolved to a concentration of 50 mg/ml. 
6.3.1.2. Antibacterial Bioassay 
The microdilution antibacterial assay (MIC bioassay) of ELOFF (1998) as 
described in Section 2.2.2.3 was used to screen the extracts for antibacterial activity. 
Four extracts per treatment per harvest were tested. The assay was repeated a 
second time giving a total of eight replicates for each treatment for each harvest. The 
extracts were tested against two Gram-positive bacteria, Bacillus subtilis (ATCC No. 
6051) and Staphylococcus aureus (ATCC No. 12600), and two Gram-negative 
bacteria Escherichia coli (ATCC No. 11775) and Klebsiella pneumoniae (ATCC No. 
13883). 
6.3.1.3. Bioautographic Assay 
Fingerprinting results of the methanol extracts showed no visual differences 
between the different treatments, therefore, only the extracts from bulbs harvested 
from the control plots were spotted and developed on TLC. Two ~I of the control 
methanol extracts from each harvest were spotted onto 2 TLC plates (silica gel 60 
F254 TLC plates, Merck). The TLC plates were developed with a chloroform: 
methanol: water (8:5: 1 v:v:v) solvent system. One plate was stained with 
anisaldehyde-sulphuric acid reagent and heated at 110°C for 8 min. The second 
plate was used in the bioautographic assay. 
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The bioautographic assay as described by MARTINI and ELOFF (1998) was 
used. The test bacterium S. aureus (ATCC No. 12600) was cultured overnight in MH 
broth medium. The cultures were centrifuged at 3000 g for 10 min and the 
supernatant discarded. The bacterial pellet was resuspended in 10 ml fresh MH broth 
and sprayed onto the developed TLC plate. The plate was then incubated overnight 
at 37°C in 100% humidity. The plate was removed and allowed to dry slightly before 
being sprayed with a 2 mg/ml solution of iodonitrotetrazolium chloride (INT) (Fluka). 
The plate was re-incubated for a further 2 h to allow for colour development. Zones of 
inhibition appear as white spots against a pink coloured background. 
6.3.2. Results and Discussion 
Minimum inhibitory concentrations (MIC) were calculated for an average of 
eight replicates for each treatment of each harvest. The MIC values of individual 
extracts were compared using Fisher's pairwise comparisons at 5% level of 
significance. The lower the MIC value, the higher the antibacterial activity. ANOVA 
was used to determine interaction and the effect of plot treatments and time of 
harvests on the MIC values. The neomycin control had MIC of 1.6 x 10-2 mg/ml 
against B. subtilis and K. pneumoniae, 3.1 x 10-2 mg/ml against S. aureus, and 6.3 x 
10-2 mg/ml against E. coli. 
The results from the antibacterial screening of bulbs cultivated at the H2A 
Botanicals site showed no significant differences (p:50.05) in activity between 
treatments against both the Gram-positive bacteria. Bulbs harvested from the 
fertilizer treatment after 12 months (September 2001) of growing in the field gave the 
highest activity (3.9 mg/ml) against B. subtilis (Figure 6.1A). Analysis of the results 
showed there to be no interaction between the treatments and the time of harvest 
(p=0.137). Both the plot treatments (Figure 6.1 B) and the time of harvest (Figure 
6.1 C) had no significant effect on the antibacterial activity (p=0.221 and p=0.184 
respectively). Bulbs harvested after just 6 months (March 2001) from the fertilizer 
treatment had the highest activity (2.34 mg/ml) against S. aureus (Figure 6.2A). 
Analysis of the antibacterial results against S. aureus showed there to be no 
interaction between the treatments and the time of harvest (p=0.278). The treatments 
had no significant effect on the antibacterial activity (Figure 6.2B). However, the time 
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of harvest (Figure 6.2C) did have a significant effect on the antibacterial aCtivity 
(p=0.002). The antibacterial activity decreased as the plants matured . The 6 month 
(March 2001) harvest had significantly higher antibacterial activity against S. aureus 
than the 24 month (September 2002) harvest. 
The screening against the Gram-negative bacteria did not show a similar 
pattern to the results for the Gram-positive bacteria. There were significant 
differences (p:50.05) in activity between treatments (Figure 6.3B). Analysis of the 
results showed that the type of treatment had a significant effect on the antibacterial 
activity against E. coli (p=0.008). Bulbs harvested from the fertilizer treatment were 
more active against E. coli than the bulbs from the other treatment. The bulbs 
harvested in March 2001 (6 months) from the fertilizer treatment had the highest 
activity (MIC = 2.73 mg/ml) (Figure 6.3A). Analysis of the results also showed that the 
time of harvest (Figure 6.3C) had a significant effect on the antibacterial activity 
(p=0.001). The antibacterial activity decreased as the plants matured. However, there 
was no interaction between the type of treatment and the time of harvest (p=0.887). 
8ulbs harvested in March 2001 (6 months) from the irrigation and fertilizer plot had 
the highest activity against K. pneumoniae (MIC = 2.73 mg/ml) (Figure 6.4A). There 
was also no significant difference in activity between bulbs harvested from the 
fertilizer treatment for all harvest times (MIC values ranged from 2.92 mg/ml to 3.13 
mg/ml). Analysis of the results showed that both the type of treatment (Figure 6.4B) 
and the time of harvest (Figure 6.4C) had no significant effect on the activity (p=0.193 
and p=0.221 respectively). However, there was a significant interaction between the 
treatment and the time of harvest (p<0.001) (Figure 6.4A). 
The results from bulbs cultivated at Fort Hare showed no significant 
differences (p:50.05) in activity between treatments against both Gram-positive test 
bacteria (Figure 6.58 and Figure 6.68). Analysis of the results showed that the type 
of treatment had no significant effect on the activity against B. subtilis (p=0.579) . The 
bulbs harvested in April 2000 (6 months) from the fertilizer treatment, had the highest 
activity against B. subtilis (Figure 6.5A) with average MIC value of 4.69 mg/ml. All the 
other harvests and treatments ranged between 5.08 mg/ml to 6.25 mg/ml, except for 
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Figure 6.1. Mean MIC values of M. nata/ensis bulb extracts harvested from the H2A 
Botanicals site over a period of two years against B. subtilis. (A) Mean MIC 
for each extract. (8) Mean MIC of each treatment. (C) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was not significant (p=O.137). The treatments and time of harvest had no 
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Figure 6.2. Mean MIC values of M. natalensis bulb extracts harvested from the H2A 
Botanicals site over a period of two years against S. aureus. (A) Mean MIC 
for each extract. (B) Mean MIC of each treatment. (C) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was not significant (p=O.278). The treatments had no significant effect on 
the antibacterial activity (p=O.076). Time of harvest had a significant effect 
on the antibacterial activity of the bulbs (p=O.002). Values within the same 
graph with the same letters are not significantly different (at 5% level of 
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Figure 6.3. Mean MIC values of M. nata/ensis bulb extracts harvested from the H2A 
Botanicals site over a period of two years against E. coli. (A) Mean MIC for 
each extract. (B) Mean MIC of each treatment. (C) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was not significant (p=O.887). Both the treatments and time of harvest had 
a significant effect on the antibacterial activity of the bulbs (p=O.008 and 
p=O.001 respectively). Values within the same graph with the same letters 
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Figure 6.4. Mean MIC values of M. natalensis bulb extracts harvested from the H2A 
Botanicals site over a period of two years against K. pneumoniae. (A) Mean 
MIC for each extract. (B) Mean MIC of each treatment. (C) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was highly significant (p<O.001). Both the treatments and time of harvest 
had no significant effect on the antibacterial activity of the bulbs (p=O.193 
and p=O.221 respectively). Values within the same graph with the same 
letters are not significantly different (at 5% level of significance) from each 
other. 
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Analysis of the results also showed that the time of harvest (Figure 6.5G) had 
a significant effect on the activity against B. subtilis (p=0.002). However, there was 
no interaction between the treatments and the time of harvest (p=0.847). Analysis of 
the results showed that the time of harvest (Figure 6.6G) had a highly significant 
effect (p:50.05) on the activity against S. aureus (p<0.001). There was also no 
interaction between the type of treatment and the time of harvest (p=0.866) . Analysis 
of the results showed that the type of treatment had no significant effect on the 
activity against S. aureus (p=0.484). The bulbs harvested from the fertilizer treatment 
and irrigation treatment had the highest activity (MIG = 2.15 mg/ml) against S. aureus 
(Figure 6.6A). 
The results of bulbs harvested from the Fort Hare site against Gram-negative 
bacteria followed similar trends in activity to the results from the Gram-positive 
bacteria. Analysis of the results showed no significant (p:50.05) interaction between 
treatments and time of harvest (p=0.983). The treatments had no significant effect on 
the antibacterial activity (p=0.583) (Figure 6.7B). There were no significant 
differences between the MIG values of the six month (April 2000) and 12 month (Nov 
2000) harvests against E. coli (Figure 6.7G), but the MIG values of both harvests 
were significantly different from both the 18 month (April 2001) and 24 month (Nov 
2001) harvests. Analysis of these results revealed the time of harvest to have a 
significant effect (p:50.05) on the antibacterial activity against E. coli (p<0.001). Bulbs 
harvested from the irrigation treatment after 6 months growth, had the highest activity 
against E. coli (MIG = 2.34 mg/ml) (Figure 6.7A). 
No real trends were noticeable from the results of K. pneumoniae as seen in 
Figure 6.8. There was no interaction between the treatments and the time of harvests 
(p=0.847). Analysis showed that the treatments (Figure 6.8B) and the time of harvest 
(Figure 6.8G) had no significant effect (p:50.05) on the antibacterial activity (p=0.071 
and p= 0.242 respectively). On average, extracts were more active against K. 
pneumoniae than against E. coli. The highest activity was recorded with the bulbs 
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Figure 6.5. Mean MIC values of M. nata/ensis bulb extracts harvested from the Fort 
Hare site over a period of two years against B. subtilis. (A) Mean MIG for 
each extract. (8) Mean MIG of each treatment. (G) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was not significant (p=O.847). The treatments had no significant effect on 
the antibacterial activity of the bulbs (p=O.579). Time of harvest had a 
significant effect on the antibacterial activity of the bulbs (p=O.002). Values 
within the same graph with the same letters are not significantly different 
(at 5% level of significance) from each other. 
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Figure 6.6. Mean MIC values of M. nata/ensis bulb extracts harvested from the Fort 
Hare site over a period of two years against S. aureus. (A) Mean MIC for 
each extract. (8) Mean MIC of each treatment. (C) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was not significant (p=O.866). The treatments had no significant effect on 
the antibacterial activity of the bulbs (p=O.484). Time of harvest had a 
significant effect on the antibacterial activity of the bulbs (p<O.001). Values 
within the same graph with the same letters are not significantly different 
(at 5% level of significance) from each other. 
88 
-





~ irrig & fert 
B. 
E 8 -0) 
E 

























c 4 c 
2 
April 2000 Nov 2000 April 2001 Nov 2001 
Time of Harvest 
Figure 6.7. Mean MIC values of M. nataiensis bulb extracts harvested from the Fort 
Hare site over a period of two years against E. coli. (A) Mean MIC for each 
extract. (8) Mean MIC of each treatment. (C) Mean MIC of each harvest. The 
interaction between the treatments and the time of harvest was not 
significant (p=~983). The treatments had no significant effect on the 
antibacterial activity of the bulbs (p=O.583). Time of harvest had a 
significant effect on the antibacterial activity of the bulbs (p<O.001). Values 
within the same graph with the same letters are not significantly different 
(at 5% level of significance) from each other. 
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Figure 6.8. Mean MIC values of M. nata/ensis bulb extracts harvested from the Fort 
Hare site over a period of two years against K. pneumoniae. (A) Mean MIC 
for each extract. (8) Mean MIC of each treatment. (C) Mean MIC of each 
harvest. The interaction between the treatments and the time of harvest 
was not significant (p=O.847). The treatments and time of harvest had no 
significant effect on the antibacterial activity of the bulbs (p=O.071 and 
p=O.242 respectively). 
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In the study by LIGHT, McGAW, RABE, SPARG, TAYLOR, ERASMUS and 
VAN STADEN (2002) it was concluded that the time of harvest of Siphonochilus 
aethiopicus only had a minimal influence (two-fold difference) on the degree of 
antibacterial activity. Although the results of this study were four-fold decrease in 
activity, the extract concentration levels were not that low to suggest that there is 
good anti-bacterial activity. The initial testing done on mature bulbs (Section 2.2) 
resulted in higher antibacterial activity. The extracts from mature bulbs were more 
active at lower concentrations. From this study it is clear that there is a definite 
decrease in antibacterial activity with an increase in age with M. natalensis. Results 
of the bioautographic assay confirmed this finding (Figure 6.9) . Zones of bacterial 
inhibition (clear zones) were seen in both the 6 and 12 month harvests (indicated by 
white arrows, Figure 6.9). These clear zones were observed in extracts of bulbs from 
both cultivation sites. Younger plants would be more susceptible to bacterial 
infections and would therefore need to have higher concentrations of antibacterial 
compounds. As was the case with the antibacterial screening (Section 2.2.3), 
extracts from M. natalensis are generally more active against Gram-negative 
bacteria. In many of the antibacterial studies that had been conducted with plant, 
extracts, it is the Gram-positive bacteria that are more sensitive than Gram-negative. 
This is due to differences in the cell wall structure of the bacteria (PAGE, CURTIS, 
SUTTER, WALKER and HOFFMAN 1997). 
6.4. Anti-inflammatory Analysis of Cultivated Bulbs 
6.4.1. Methodology 
6.4.1.1. Extracts 
Dichloromethane extracts were tested for COX-1 inhibition only as these 
extracts showed the highest anti-inflammatory activity in initial screening (Section 
2.3.3). The dichloromethane extracts were dissolved in ethanol to a concentration of 
10 mglml (250 !-Ig/ml per test solution). 
91 
CHAPTER 6 PHARMACOLOGICAL ANALYSIS OF MATERIAL COLLECTED FROM FIELD TRIALS 
o - 0 , 
.... 
/" ' .. 




1 H2 H3 tl4 f1 f-2 ,f 3 ~ 
Figure 6.9. Bioautographic assay - TLC plates of M. nata/ensis methanol extracts 
from bulbs harvested from the control treatment from both the H2A 
Botanicals and the Fort Hare sites. TLC plates were developed with a 
chloroform: methanol: water (8:5:1 v:v:v) solvent system. (A) Reference 
TLC plate stained with anisaldehyde-sulphuric acid reagent. (B) 
Corresponding TLC plate with S. aureus bacterial overlay. Clear zones 
indicate zones of bacterial inhibition. H = H2A Botanicals. F = Fort Hare. 1 
- 4 = Harvests (6, 12, 18 and 24 months). 
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6.4 .1.2. Anti-inflammatory Bioassay 
Extracts were screened using the COX-1 assay as described in Section 2.3.2. 
Four extracts per treatment per harvest were tested. One replicate of each of the 
extracts was performed. The assay was repeated a second time giving a total of 8 
replicates for each treatment for each harvest. 
6.4.2. Results and Discussion 
The mean percentage inhibitions were calculated as a mean of eight replicates 
for each treatment of each harvest. The means were compared using Fisher's 
pairwise comparisons at 5% level of significance. ANOVA was used to determine the 
significance of interactions and effects of plot treatments and time of harvests on anti-
inflammatory activity. The indomethacin control had 59% COX-1 inhibition. 
Results from the screening indicate that COX-1 inhibition by both young and 
mature bulbs cultivated at H2A Botanicals are high. No significant differences 
(p!50.05) in activity were noticed between different treatments. The percentage 
inhibition ranged from 88% to 91 % (Figure 6.1 OA). Analysis showed that treatments 
(Figure 6.10B) had no effect on COX-1 inhibition (p=0.613). There was also no 
interaction between the treatments and the time of harvest (p=0.985). The time of 
harvest (Figure 6.1 ~C) also did not have a significant effect (p!50.05) on inhibiting the 
action of the COX-1 enzyme in prostaglandin synthesis (p=0.613). 
The bulbs harvested from the Fort Hare site showed similar patterns as the 
bulbs harvested from H2A Botanicals. The percentage COX-1 inhibition ranged from 
88% to 96% (Figure 6.11A). The dichloromethane extracts from bulbs harvested from 
the control treatment had the highest activity, inhibiting 96% of the enzyme action in 
prostaglandin synthesis. The COX-1 inhibition was significantly different (p!50.05) 
from all the other extracts. There was no interaction between the treatments and the 
time of harvest (p=550). The type of treatment (Figure 6.11 B) also showed no 
significant (p!50.05) effect on the inhibition (p=0.881). However, the time of harvest 
(Figure 6.11 C) did have a significant effect (p!50.05) on inhibiting the enzyme action 
in prostaglandin synthesis (p=0.011). 
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Figure 6.10. Mean percentage inhibition of COX-1 enzyme by M. natalensis bulb 
extracts. Bulbs harvested from the H2A Botanicals site. (A) Mean inhibition 
for each extract. (B) Mean inhibition of each treatment. (C) Mean inhibition 
of each harvest. There was no significant (p:S0.05) interaction between the 
treatments and the time of harvest (p=0.985). The treatments had no 
significant effect on COX-1 inhibition (p=0.613). Time of harvest had no 
significant effect on COX-1 inhibition (p=0.128). 
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Figure 6.11. Mean percentage inhibition of COX-1 enzyme by M. natalensis bulb 
extracts. Bulbs harvested from the Fort Hare site. (A) Mean inhibition for 
each extract. (B) Mean inhibition of each treatment. (C) Mean inhibition of 
each harvest. There was no significant (p~O.05) interaction between the 
treatments and the time of harvest (p=O.550). The treatments had no 
significant effect on COX-1 inhibition (p=O.881). Time of harvest had a 
significant effect on COX-1 inhibition (p=O.011). Values within the same 
graph with the same letters are not significantly different (at 5% level of 
significance) from each other. 
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LIGHT, McGAW, RABE, SPARG, TAYLOR, ERASMUS and VAN STADEN 
(2002) showed that there was little seasonal variation on anti-inflammatory activity in 
Siphonochilus aethiopicus. However, TAYLOR and VAN STADEN (2001) showed 
that the age of Eucomis autumnalis bulbs had an effect on COX-1 inhibition. The 
bulbs of mature plants were more active than the bulbs of younger plants. There 
were also differences in activity over the seasons. The highest activity was detected 
towards the end of the growing season, shortly before the onset of dormancy. 
Results from the Fort Hare site, indicates that the COX-1 inhibitory activity was 
effected by the time of harvest, and that the younger plants had higher activity. This 
would mean that young bulbs can potentially be used in the treating inflammation. 
TAYLOR and VAN STADEN (2002) showed that the environmental conditions during 
the period of winter dormancy effect the levels of anti-inflammatory activity that was 
exhibited by Eucomis autumnalis autumnalis bulbs. However, the results of M. 
natalensis, indicates that winter dormancy had no effect on the levels of COX-1 
inhibitory activity. 
6.5. Anthelmintic Analysis of Cultivated Bulbs 
6.5.1. Methodology 
6.5 .1.1. Extracts 
Dichloromethane extracts were tested against Caenorhabditis elegans only as 
these extracts showed the highest anthelmintic activity (Section 2.5.3). The 
dichloromethane extracts were dissolved in ethanol to a concentration of 100 mg/ml 
(1 mg/ml per test solution). 
6.5.1.2. Anthelmintic Bioassay 
The nematode Caenorhabditis e/egans var. Bristol (N2) was cultured on 
nematode growth agar seeded with E. coli according to the method of BRENNER 
(1974). The anthelmintic assay used was the method of RASOANAIVO and 
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RATSIMAMANGA-URVERG (1993) as described by McGAW, JAGER and VAN 
STADEN (2000) (Section 2.5.2). Four extracts per treatment per harvest were tested. 
One replicate of each of the extracts was performed. The assay was repeated a 
second time giving a total of 8 replicates for each treatment for each harvest. 
6.5.2 . Results and Discussion 
The percentage survival of the nematodes was calculated as a mean of eight 
replicates for each treatment of each harvest. The means were compared using 
Fisher's pairwise comparisons at 5% level of significance. ANOVA was used to 
determine the significance of interactions and effects of treatments and time of 
harvest on anthelmintic activity. The levamisole control killed approximately 40% of 
the nematodes (i.e. a survival rate of 60%). 
Methanol extracts from the bulbs of cultivated M. natalensis were did not show 
high in activity as was observed during initial anthelmintic screening (Section 2.5.4). 
Results of bulbs from the H2A Botanicals site are given in Figure 6.12. The methanol 
extracts killed between 30 and 40% (i.e. a survival rate of between 60 and 70%) of the 
C. elegans nematodes after 2 h (Figure 6.12A). There was no significant interaction 
between the treatments and the time of harvest (p = 0.510). The treatments as 
presented in Figure 6.12B had no significant (psO.05) effect on the anthelmintic activity 
(p = 0.092). There was a clear increase in activity as the plants matured. Figure 6.12C 
shows that the extracts of bulbs harvested after 24 months were more lethal to C. 
elegans. Analysis indicates that the time of harvest did have a significant effect (psO.OS) 
on the anthelmintic activity (p = 0.020). Bulbs harvested from both the fertilizer 
treatment and the irrigation treatment after 24 months had the highest activity, killing 
approximately 40% of the nematodes. The 6 month harvest from the control treatment 
had the weakest activity leading to approximately 30% nematode mortality. 
Similar results were shown for the methanol extracts of bulbs cultivated at Fort 
Hare (Figure 6.13). The extracts killed between 30 and 40% (i.e. a survival rate of 
between 60 and 70%) of the C. elegans nematodes after 2 h (Figure 6.13A). Similarly to 
the H2A Botanicals results, no significant (pSO.05) interaction between the treatments 
and the time of harvest (p= 0.998) was noted. However, the treatments were found to 
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have a significant effect (psO.05) on the anthelmintic activity (p = 0.024). The bulbs 
harvested from the irrigation treatment had the highest activity, killing on average 37% 
of the nematodes (Figure 6.13B). There were no significant differences between the 
activity from bulbs harvested from the control treatment and the fertilizer treatment. This 
suggests that irrigation could have an effect on the anthelmintic activity of the bulbs. 
The average annual rainfall at Fort Hare is lower than at H2A Botanicals. Therefore, the 
irrigation treatment at the H2A Botanical site did not have a significant effect on the 
anthelmintic activity. From the results of bulbs harvested from the Fort Hare site it can 
be seen that irrigation could increase the anthelmintic activity of M. natalensis bulbs if 
grown in an area where the mean annual rainfall is around 600 mm. However, because 
both cultivation sites used different fertilizers in their treatments, the sites cannot be 
compared properly. The inorganic fertil izer used at the Fort Hare site, combined with 
irrigation could have effected the chemical composition of the bulbs. The time of harvest 
had a significant effect (psO.05) on the anthelmintic activity (p < 0.001). The more 
mature bulbs were more active against C. elegans, killing on average 41 % of the 
nematodes (Figure 6.13C). Young bulbs harvested after 6 months of cultivation killed 
only 30% of the nematodes. 
Although the differences in anthelmintic activity were statistically significant, it 
must be remembered that the results are estimated at a 5% range. The results from this 
in vitro study indicate that mature plants could be used in the treatment of intestinal 
worms (nematodes). However, further in vivo testing would be necessary to investigate 
levels of toxicity. 
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Figure 6.12. Percentage of Caenorhabitis e/egans nematodes alive after being exposed 
to methanol extracts of M. nata/ensis bulbs harvested from the H2A 
Botanicals site. (A) Mean percentage of nematodes surviving for each 
extract. (B) Mean percentage of nematodes surviving for each treatment. 
(C) Mean percentage of nematodes surviving for each harvest. The 
interaction between the treatments and the time of harvest was not 
significant (p=O.510). The treatments had no significant effect (p~O.05) on 
the anthelmintic activity (p=O.092). The time of harvest had a significant 
effect on the anthelmintic activity (p=O.020). 
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Figure 6.13. Percentage of Caenorhabitis e/egans nematodes alive after being exposed 
to methanol extracts of M. nata/ensis bulbs harvested from the Fort Hare 
site. (A) Mean percentage of nematodes surviving for each extract. (8) 
Mean percentage of nematodes surviving for each treatment. (C) Mean 
percentage of nematodes surviving for each harvest. The interaction 
between the treatments and the time of harvest was not significant 
(p=O.998). The treatments and time of harvest had a significant effect on 
the anthelmintic activity (p=O.024 and p<O.001 respectively). 
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6.6. Summary 
• Variations in antibacterial activity were recorded from bulbs cultivated at both 
growing site. 
• In most cases, the treatments had no significant effect (p:::;O .05) on the 
antibacterial activity against all test bacteria. However, the treatments did have a 
significant effect (p:::;O.05) against E. coli with bulbs grown at the H2A Botanicals 
site. The bulbs from the fertilizer treatment were more active against E. coli than 
the bulbs from the other treatments. 
• The time of harvest had a significant effect (p:::;O .05) against both Gram-positive 
bacteria (B. subtilis and S. aureus) as well as against E. coli. In cases where the 
time of harvest had a significant effect on antibacterial activity, the younger 
plants had higher activity. Activity seemed to decrease with age. 
• Dichloromethane extracts from bulbs grown at both sites had high COX-1 
inhibitory activity. Bulbs harvested from the H2A Botanicals site showed between 
88 and 91 % inhibition. Bulbs harvested from the Fort Hare site had between 88 
and 96% inhibition. 
• There were no significant (p:::;O.05) interactions between treatments and the time 
of harvest on the anti-inflammatory activity. 
• The treatments had no significant effect (p:::;O.05) on the anti-inflammatory 
activity. 
• The time of harvest at the Fort Hare site had a significant effect (p:::;O.05) on the 
inhibition of prostaglandin synthesis by COX-1. The younger plants had higher 
COX-1 inhibition activity than the mature plants. 
• Methanol extracts from bulbs cultivated at both sites had slightly lower 
anthelmintic activity against C. elegans than the methanol extracts of mature 
bulbs (Section 2.5.4). 
• There were no significant (p:::;O.05) interactions between the treatments and the 
time of harvest with the anthelmintic activity. 
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• The treatments had no significant effect (pS;O.05) on the anthelmintic activity of 
bulbs cultivated at the H2A Botanicals site. However, the treatments did have a 
significant effect (ps;O.05) on the anthelmintic activity of bulbs cultivated at the 
Fort Hare site. Results suggest that irrigation might increase the anthelmintic 
activity of the bulbs if cultivated in areas of low rainfall. 
• The time of harvest at both sites was found to have a significant effect (ps;O.05) 
on the anthelmintic activity. Activity was found to increase with plant maturity. 
102 
CHAPTER 7 CONCLUSIONS 
Until recently, medicinal plants have been primarily collected from the wild. 
With the increase in cultivation and the use of medicinal plants, a fundamental 
understanding of the processes involved in cultivating a medicinal plant such as 
Merwilla natalensis as a crop for small scale farming is needed. There are many 
problems that can be anticipated as more medicinal plants are domesticated and 
introduced into cultivation. The successful development of M. natalensis as a 
domestic crop indicates that some species can be introduced into cultivation with 
very little changes in growth, development, and chemical content or activity. 
However, before any plant can be introduced into cultivation, levels of 
pharmacological activity and basic chemical composition of wild populations need to 
be analysed. 
The work presented in this thesis encompassed different areas of study that 
are important in obtaining a better understanding of plants used in southern Africa for 
traditional medicine and the processes involved in introducing bulbous medicinal 
plants into cultivation. The first investigation centred on the screening of M. 
natalensis for pharmacological activity. This involved a broad screening of different 
solvent extracts ranging in polarity. The second aspect was centred on the 
phytochemical screening of M. natalensis bulbs for saponins, cardiac glycosides, 
alkaloids and tannins. The third aspect of this project was centred around the 
cultivation of M. natalensis as a crop for small-scale farming . This study, involved the 
analysis of the growth of cultivated plants to determine rates of growth and suitable 
growing conditions. A forth aspect of this project concentrated on developing a TLC 
fingerprinting system and TLC fingerprinting profiles of the cultivated plants. The final 
aspect of the project centred on screening the cultivated plants for pharmacological 
activity. This study involved analysis of the effect of growth conditions and times of 
harvest on the pharmacological activity of the product. 
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7.1. Pharmacological Investigation of Merwilla natalensis 
M. natalensis bulb extracts exhibited a range of pharmacological activities. 
Methanol extracts had good antibacterial activity against both Gram-positive and 
Gram-negative test bacteria as well as good anthelmintic activity. Aqueous extracts 
(0.4 mg/ml) of both fresh and dry material yielded very high antischistosomal activity. 
Non-polar extracts were found to have high anti-inflammatory activity against 
both COX-1 and -2. Although non-polar solvents are not accessible to traditional 
healers, the levels of activity shown in these screenings, confirmed the plants usage 
in traditional medicine. Cytotoxicity testing showed the bulbs to be highly cytotoxic 
against VK cells killing 44% of the cells at a concentration of 3.9 !-Ig/ml. 
7.2. Phytochemical Screening 
Phytochemical screening revealed two major groups of compounds within the 
bulbs of M. natalensis. The bulbs contain saponins, which appear to make up a large 
portion of the chemical composition of the bulbs. The other group was bufadienolide-
type cardiac glycosides of which it seems that proscillaridin A is one. The 
pharmacological activity shown by the bulb extracts could be attributed to these two 
groups of compounds. Screenings for alkaloids and tannins came up negative. 
7.3. Growth Analysis of Material Collected From Field Trials 
M. natalensis plants were cultivated at two different sites that experience 
different climatic conditions. Bulbs grew successfully at both sites, reaching almost 
marketable size (±300 g fresh weight) two years after being planted out into the field . 
Bulb size was found not to be dependent on additional fertilizer or irrigation. 
The plants started flowering after two years, with the highest percentage 
flowering in the irrigation and fertilizer plot. Leaf senescence and dormancy of young 
plants were prevented with the addition of irrigation. However, the annual growth 
cycles were found to resume as the plants matured. 
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7.4. Chemical Fingerprinting By TLC 
TLC fingerprinting profiles were developed for methanol, dichloromethane and 
water extracts of mature wild M. natalensis bulbs. Comparisons between the mature 
wild bulbs and the harvested bulbs from both the cultivation sites were done. The 
methanol and water extracts showed some differences in chemical composition. 
Differences were most pronounced in the bulbs harvested from the Fort Hare site. No 
differences in the chemical constituents were found between the dichloromethane 
extracts. However, there were noticeable differences in the concentrations of certain 
compounds. 
7.5. Pharmacological Analysis of Material Collected From Field Trials 
Pharmacological analysis of the harvested material did demonstrate some 
statistically significant variations in the activity of the bulbs. Antibacterial screenings 
showed that the activity of younger plants is higher, with the activity decreasing as 
the plants mature. The treatments did not have a significant effect (pSO.05) on the 
activity. Anti-inflammatory screenings against COX-1 showed no significant 
differences (pSO.05) in activity with plant age. As with the antibacterial activity, the 
treatments had no significant effect (psO.05) on the anti-inflammatory activity. The 
anthelmintic screenings against Caenorhabditis elegans showed that the activity 
increased as the bulbs mature. Plants cultivated in areas of lower rainfall, under 
irrigation, had higher activity that plants that were not irrigated. However, in areas 
where the mean annual rainfall is higher than 1000 mm the application of irrigation 
did not increase the biological activity of M. natalensis bulbs. 
The results indicate that M. natalensis is a hardy species. Generally the 
application of supplementary fertilizer or irrigation did not appear to affect the 
pharmacological activity of the bulbs. In most cases the time of harvest had a 
significant effect (psO.05) on the activity. However, the plants were only cultivated for 
a period of two years and the activity levels achieved were generally lower than the 
activity levels of the mature plants in the initial screenings (Chapter 2). This means 
that growing the plants to a fully mature stage would probably be more beneficial to 
farmers who wish to cultivate and sell the bulbs. The larger bulbs would fetch higher 
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prices at markets even though certain biological activity levels of the bulbs may be 
slightly lowered. 
7.S. Conclusion 
This thesis represents an extensive investigation into the medicinal properties of 
M. natalensis and rationalise its importance as a medicinal plant. This study provides 
scientific verification for the use of M. natalensis in medicinal preparations. The 
investigation into the introduction to cultivation has not only provided much of the 
information needed for cultivating this species as a crop by small-scale farmer, but it 
has also allowed collection of information useful to provide for ecological sustainability. 
The successful domestication along with the pharmacological evidence shows that 
through cultivation the activity of indigenous medicinal plants is not necessarily lost but 
is in most cases dependent on the time of harvesting. This work therefore provides 
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